{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"103","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"G","per_page":12,"people":[{"id":444204,"version":1,"owner_type":"Person","owner_id":2836,"payload":{"bio":"\u003cp\u003eBryant Gatrell is a partner in our Corporate, Finance \u0026amp; Investments\u0026nbsp;Practice Group.\u0026nbsp; He focuses his practice on the representation of financial institutions in leveraged, asset based and investment grade financings, as well as workouts and restructurings. \u0026nbsp;Bryant has extensive experience representing Fortune 50 financial institutions, private debt funds, BDC's,\u0026nbsp;bondholders, lender groups, and other material stakeholders in complex financings throughout the capital structure, including unitranche and cross-border financings, in-court and out-of-court business reorganizations and debt restructurings.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith more than twenty-five years\u0026nbsp;of experience, Bryant helps clients structure, negotiate and close financial transactions and restructurings in a wide array of industries, including telecom, media and technology, infrastructure, retail, restaurant, franchise and hospitality, healthcare and pharmaceutical, defense and aerospace, energy, transportation, commercial real estate and general industrial. Clients rely on his knowledge of the market and his commercial approach to closing deals to provide superior service to their customers in an increasingly competitive environment. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eSome of Bryant\u0026rsquo;s recent significant representations include advising:\u0026nbsp;\u0026nbsp;\u003cstrong\u003eAntares Capital LP\u003c/strong\u003e, as agent and lead arranger, in a $3,610,000,000 unitranche facility for a\u0026nbsp;diversified insurance brokerage\u0026nbsp;company;\u003cstrong\u003e\u0026nbsp;Webster Bank, N.A.\u003c/strong\u003e, as agent and lead arranger, in connection with Everstream Solutions, LLC\u0026rsquo;s purchase of fiber assets out of the Chapter 11 bankruptcy of Great Lakes Comnet and Comlink; Capital One, National Association, as agent, in connection with an asset based lending facility for an e-commerce company providing outdoor cooking and living products;\u0026nbsp;\u003cstrong\u003eCapital One, N.A.\u003c/strong\u003e, as agent and lead arranger, in connection with an asset based facility for bbq grill manufacturer;\u0026nbsp;\u003cstrong\u003eGolub Capital LLC\u003c/strong\u003e, as agent and arranger, in connection with a secured credit facility to finance the acquisition of an addiction treatment company;\u0026nbsp;\u003cstrong\u003eMarathon Asset Management\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eChurchill Asset Management\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eMJX Asset Management\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eAllianz\u003c/strong\u003e\u0026nbsp;in connection with a super senior term loan to one of the largest car rental wholesale companies;\u0026nbsp;\u003cstrong\u003eWells Fargo Bank, National Association\u003c/strong\u003e, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers; a\u0026nbsp;\u003cstrong\u003esteering committee of term loan lenders\u003c/strong\u003e\u0026nbsp;of Vince, LLC;\u0026nbsp;\u003cstrong\u003eGoldman Sachs, Cerberus Capital Management, Arbour Lane Capital Management\u0026nbsp;\u003c/strong\u003eand\u003cstrong\u003e\u0026nbsp;other members of an ad hoc group of first lien and second lien lenders\u003c/strong\u003e\u0026nbsp;in an out-of-court restructuring of $450,000,000 in debt to a leading provider of visual marketing products for retailers, restaurants, movie studios and other entertainment companies, and medical service providers;\u0026nbsp;\u003cstrong\u003eU.S. Bank, N.A.\u003c/strong\u003e, as administrative agent and arranger, in connection a $3,750,000,000 vehicle floorplan facility for one of the largest automotive retailers in the United States; and\u0026nbsp;\u003cstrong\u003eCredit Suisse AG, Cayman Islands Branch\u003c/strong\u003e, as agent, and a\u003cstrong\u003e\u0026nbsp;steering committee of senior secured lenders\u003c/strong\u003e\u0026nbsp;in the prepackaged Chapter 11 cases of Fairway Group Holdings Corp.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePresentations, Speeches and Articles\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eFranchise Times Finance and Growth Conference\u003cbr /\u003e\u0026ldquo;Financial Covenants\u0026rdquo;\u003cbr /\u003e\u0026ldquo;Middle Market Leveraged Finance Trends\u0026rdquo;\u003cbr /\u003e\u0026ldquo;Middle Market Leveraged Finance\u0026rdquo;\u003cbr /\u003e\u0026ldquo;Sponsors\u0026rsquo; View of Term Sheets\u0026rdquo;\u003c/p\u003e","slug":"bryant-gatrell","email":"bgatrell@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented \u003cstrong\u003eWebster Bank, N.A.\u003c/strong\u003e, as agent and lead arranger, in providing senior secured credit facilities for the purchase by fiber network operator Everstream Solutions, LLC of the assets of Great Lakes Comnet and Comlink (GLC) out of GLC\u0026rsquo;s Chapter 11 bankruptcy.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eBenefit Street Partners, LLC\u003c/strong\u003e, as agent and lead arranger, in providing senior secured credit facilities to \u003cstrong\u003eInventure Foods Inc.\u003c/strong\u003e, a leading specialty food marketing and manufacturer.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eWells Fargo Bank, National Association\u003c/strong\u003e, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eGSO Capital Partners\u003c/strong\u003e as a lender in the Chapter 11 cases of \u003cstrong\u003eRoadhouse Holding Inc. (a/k/a Logan's Roadhouse)\u003c/strong\u003e and its affiliated debtors. \u0026nbsp;During the Chapter 11 cases, Logan's successfully optimized its restaurant portfolio and substantially deleveraged its capital structure.\u0026nbsp; King \u0026amp; Spalding now serves as corporate counsel to Logan\u0026rsquo;s Roadhouse post-restructuring.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eSunTrust Bank\u003c/strong\u003e, as agent and arranger, in providing senior secured credit facilities for an outpatient radiology center company.\u003c/p\u003e","\u003cp\u003eRepresented a \u003cstrong\u003esteering committee of term loan lenders\u003c/strong\u003e under the senior secured term loan facility in favor of \u003cstrong\u003eVince, LLC\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented an \u003cstrong\u003einvestment fund\u003c/strong\u003e in financing the acquisition by a private equity firm of a company providing drug and alcohol addiction treatment services.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eCredit Suisse AG, Cayman Islands Branch\u003c/strong\u003e, as agent under a senior secured credit facility (and subsequent DIP and exit facilities), and a steering committee of senior secured lenders, in the prepackaged chapter 11 cases of \u003cstrong\u003eFairway Group Holdings Corp.\u003c/strong\u003e and its subsidiaries.\u0026nbsp; Fairway\u0026rsquo;s Chapter 11 has been recognized as the 2017 Consumer Staples Deal of the Year (Over $100 Million) by The M\u0026amp;A Advisor and the 2017 Turnaround Atlas Award for Pre-Pack Restructuring of the Year (Under $1 Billion) by Global M\u0026amp;A Network.\u0026nbsp; King \u0026amp; Spalding now serves as corporate counsel to Fairway post-restructuring.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eModern Bank, N.A.\u003c/strong\u003e, as agent and lender, in providing a senior secured delayed draw term loan facility to The Smilist Management, Inc. to support its future purchase of dental practices.\u003c/p\u003e","\u003cp\u003eRepresented a steering committee of senior secured term lenders under a senior secured credit facility (and subsequent DIP and exit facilities) in the Chapter 11 cases of \u003cstrong\u003eBoomerang Tube, LLC\u003c/strong\u003e and its affiliates.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eGeneral Electric Capital Corporation\u003c/strong\u003e, as agent, in connection with a senior secured asset-based lending facility in favor of \u003cstrong\u003eBrookstone Company, Inc\u003c/strong\u003e., the proceeds of which financed, in part, Brookstone\u0026rsquo;s acquisition by affiliates of Chinese investment fund The Sanpower Group.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eCitizens Bank, National Association\u003c/strong\u003e, as agent and lead arranger, in connection with a senior secured financing for a media company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eGeneral Electric Capital Corporation\u003c/strong\u003e, as agent, in connection with a senior secured asset-based lending facility in favor of \u003cstrong\u003eRadioShack Corporation\u003c/strong\u003e.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":85}]},"expertise":[{"id":26,"guid":"26.capabilities","index":0,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":104,"guid":"104.capabilities","index":3,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":4,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":5,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":6,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":7,"source":"capabilities"},{"id":734,"guid":"734.smart_tags","index":8,"source":"smartTags"},{"id":36,"guid":"36.capabilities","index":9,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":10,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":11,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":12,"source":"capabilities"}],"is_active":true,"last_name":"Gatrell","nick_name":"Bryant","clerkships":[],"first_name":"Matthew","title_rank":9999,"updated_by":101,"law_schools":[{"id":2237,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":1,"graduation_date":"1996-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"Bryant","name_suffix":"","recognitions":[{"title":"Banking and Finance Law ","detail":"The Best Lawyers in America, 2013–2017"}],"linked_in_url":"https://www.linkedin.com/in/bryant-gatrell-400b2316/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBryant Gatrell is a partner in our Corporate, Finance \u0026amp; Investments\u0026nbsp;Practice Group.\u0026nbsp; He focuses his practice on the representation of financial institutions in leveraged, asset based and investment grade financings, as well as workouts and restructurings. \u0026nbsp;Bryant has extensive experience representing Fortune 50 financial institutions, private debt funds, BDC's,\u0026nbsp;bondholders, lender groups, and other material stakeholders in complex financings throughout the capital structure, including unitranche and cross-border financings, in-court and out-of-court business reorganizations and debt restructurings.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eWith more than twenty-five years\u0026nbsp;of experience, Bryant helps clients structure, negotiate and close financial transactions and restructurings in a wide array of industries, including telecom, media and technology, infrastructure, retail, restaurant, franchise and hospitality, healthcare and pharmaceutical, defense and aerospace, energy, transportation, commercial real estate and general industrial. Clients rely on his knowledge of the market and his commercial approach to closing deals to provide superior service to their customers in an increasingly competitive environment. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eSome of Bryant\u0026rsquo;s recent significant representations include advising:\u0026nbsp;\u0026nbsp;\u003cstrong\u003eAntares Capital LP\u003c/strong\u003e, as agent and lead arranger, in a $3,610,000,000 unitranche facility for a\u0026nbsp;diversified insurance brokerage\u0026nbsp;company;\u003cstrong\u003e\u0026nbsp;Webster Bank, N.A.\u003c/strong\u003e, as agent and lead arranger, in connection with Everstream Solutions, LLC\u0026rsquo;s purchase of fiber assets out of the Chapter 11 bankruptcy of Great Lakes Comnet and Comlink; Capital One, National Association, as agent, in connection with an asset based lending facility for an e-commerce company providing outdoor cooking and living products;\u0026nbsp;\u003cstrong\u003eCapital One, N.A.\u003c/strong\u003e, as agent and lead arranger, in connection with an asset based facility for bbq grill manufacturer;\u0026nbsp;\u003cstrong\u003eGolub Capital LLC\u003c/strong\u003e, as agent and arranger, in connection with a secured credit facility to finance the acquisition of an addiction treatment company;\u0026nbsp;\u003cstrong\u003eMarathon Asset Management\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eChurchill Asset Management\u003c/strong\u003e,\u0026nbsp;\u003cstrong\u003eMJX Asset Management\u003c/strong\u003e\u0026nbsp;and\u0026nbsp;\u003cstrong\u003eAllianz\u003c/strong\u003e\u0026nbsp;in connection with a super senior term loan to one of the largest car rental wholesale companies;\u0026nbsp;\u003cstrong\u003eWells Fargo Bank, National Association\u003c/strong\u003e, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers; a\u0026nbsp;\u003cstrong\u003esteering committee of term loan lenders\u003c/strong\u003e\u0026nbsp;of Vince, LLC;\u0026nbsp;\u003cstrong\u003eGoldman Sachs, Cerberus Capital Management, Arbour Lane Capital Management\u0026nbsp;\u003c/strong\u003eand\u003cstrong\u003e\u0026nbsp;other members of an ad hoc group of first lien and second lien lenders\u003c/strong\u003e\u0026nbsp;in an out-of-court restructuring of $450,000,000 in debt to a leading provider of visual marketing products for retailers, restaurants, movie studios and other entertainment companies, and medical service providers;\u0026nbsp;\u003cstrong\u003eU.S. Bank, N.A.\u003c/strong\u003e, as administrative agent and arranger, in connection a $3,750,000,000 vehicle floorplan facility for one of the largest automotive retailers in the United States; and\u0026nbsp;\u003cstrong\u003eCredit Suisse AG, Cayman Islands Branch\u003c/strong\u003e, as agent, and a\u003cstrong\u003e\u0026nbsp;steering committee of senior secured lenders\u003c/strong\u003e\u0026nbsp;in the prepackaged Chapter 11 cases of Fairway Group Holdings Corp.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePresentations, Speeches and Articles\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eFranchise Times Finance and Growth Conference\u003cbr /\u003e\u0026ldquo;Financial Covenants\u0026rdquo;\u003cbr /\u003e\u0026ldquo;Middle Market Leveraged Finance Trends\u0026rdquo;\u003cbr /\u003e\u0026ldquo;Middle Market Leveraged Finance\u0026rdquo;\u003cbr /\u003e\u0026ldquo;Sponsors\u0026rsquo; View of Term Sheets\u0026rdquo;\u003c/p\u003e","matters":["\u003cp\u003eRepresented \u003cstrong\u003eWebster Bank, N.A.\u003c/strong\u003e, as agent and lead arranger, in providing senior secured credit facilities for the purchase by fiber network operator Everstream Solutions, LLC of the assets of Great Lakes Comnet and Comlink (GLC) out of GLC\u0026rsquo;s Chapter 11 bankruptcy.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eBenefit Street Partners, LLC\u003c/strong\u003e, as agent and lead arranger, in providing senior secured credit facilities to \u003cstrong\u003eInventure Foods Inc.\u003c/strong\u003e, a leading specialty food marketing and manufacturer.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eWells Fargo Bank, National Association\u003c/strong\u003e, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eGSO Capital Partners\u003c/strong\u003e as a lender in the Chapter 11 cases of \u003cstrong\u003eRoadhouse Holding Inc. (a/k/a Logan's Roadhouse)\u003c/strong\u003e and its affiliated debtors. \u0026nbsp;During the Chapter 11 cases, Logan's successfully optimized its restaurant portfolio and substantially deleveraged its capital structure.\u0026nbsp; King \u0026amp; Spalding now serves as corporate counsel to Logan\u0026rsquo;s Roadhouse post-restructuring.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eSunTrust Bank\u003c/strong\u003e, as agent and arranger, in providing senior secured credit facilities for an outpatient radiology center company.\u003c/p\u003e","\u003cp\u003eRepresented a \u003cstrong\u003esteering committee of term loan lenders\u003c/strong\u003e under the senior secured term loan facility in favor of \u003cstrong\u003eVince, LLC\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eRepresented an \u003cstrong\u003einvestment fund\u003c/strong\u003e in financing the acquisition by a private equity firm of a company providing drug and alcohol addiction treatment services.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eCredit Suisse AG, Cayman Islands Branch\u003c/strong\u003e, as agent under a senior secured credit facility (and subsequent DIP and exit facilities), and a steering committee of senior secured lenders, in the prepackaged chapter 11 cases of \u003cstrong\u003eFairway Group Holdings Corp.\u003c/strong\u003e and its subsidiaries.\u0026nbsp; Fairway\u0026rsquo;s Chapter 11 has been recognized as the 2017 Consumer Staples Deal of the Year (Over $100 Million) by The M\u0026amp;A Advisor and the 2017 Turnaround Atlas Award for Pre-Pack Restructuring of the Year (Under $1 Billion) by Global M\u0026amp;A Network.\u0026nbsp; King \u0026amp; Spalding now serves as corporate counsel to Fairway post-restructuring.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eModern Bank, N.A.\u003c/strong\u003e, as agent and lender, in providing a senior secured delayed draw term loan facility to The Smilist Management, Inc. to support its future purchase of dental practices.\u003c/p\u003e","\u003cp\u003eRepresented a steering committee of senior secured term lenders under a senior secured credit facility (and subsequent DIP and exit facilities) in the Chapter 11 cases of \u003cstrong\u003eBoomerang Tube, LLC\u003c/strong\u003e and its affiliates.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eGeneral Electric Capital Corporation\u003c/strong\u003e, as agent, in connection with a senior secured asset-based lending facility in favor of \u003cstrong\u003eBrookstone Company, Inc\u003c/strong\u003e., the proceeds of which financed, in part, Brookstone\u0026rsquo;s acquisition by affiliates of Chinese investment fund The Sanpower Group.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eCitizens Bank, National Association\u003c/strong\u003e, as agent and lead arranger, in connection with a senior secured financing for a media company.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong\u003eGeneral Electric Capital Corporation\u003c/strong\u003e, as agent, in connection with a senior secured asset-based lending facility in favor of \u003cstrong\u003eRadioShack Corporation\u003c/strong\u003e.\u003c/p\u003e"],"recognitions":[{"title":"Banking and Finance Law ","detail":"The Best Lawyers in America, 2013–2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":868}]},"capability_group_id":1},"created_at":"2025-12-12T04:52:29.000Z","updated_at":"2025-12-12T04:52:29.000Z","searchable_text":"Gatrell{{ FIELD }}{:title=\u0026gt;\"Banking and Finance Law \", :detail=\u0026gt;\"The Best Lawyers in America, 2013–2017\"}{{ FIELD }}Represented Webster Bank, N.A., as agent and lead arranger, in providing senior secured credit facilities for the purchase by fiber network operator Everstream Solutions, LLC of the assets of Great Lakes Comnet and Comlink (GLC) out of GLC’s Chapter 11 bankruptcy.{{ FIELD }}Represented Benefit Street Partners, LLC, as agent and lead arranger, in providing senior secured credit facilities to Inventure Foods Inc., a leading specialty food marketing and manufacturer.{{ FIELD }}Represented Wells Fargo Bank, National Association, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers.{{ FIELD }}Represented GSO Capital Partners as a lender in the Chapter 11 cases of Roadhouse Holding Inc. (a/k/a Logan's Roadhouse) and its affiliated debtors.  During the Chapter 11 cases, Logan's successfully optimized its restaurant portfolio and substantially deleveraged its capital structure.  King \u0026amp; Spalding now serves as corporate counsel to Logan’s Roadhouse post-restructuring.{{ FIELD }}Represented SunTrust Bank, as agent and arranger, in providing senior secured credit facilities for an outpatient radiology center company.{{ FIELD }}Represented a steering committee of term loan lenders under the senior secured term loan facility in favor of Vince, LLC.{{ FIELD }}Represented an investment fund in financing the acquisition by a private equity firm of a company providing drug and alcohol addiction treatment services.{{ FIELD }}Represented Credit Suisse AG, Cayman Islands Branch, as agent under a senior secured credit facility (and subsequent DIP and exit facilities), and a steering committee of senior secured lenders, in the prepackaged chapter 11 cases of Fairway Group Holdings Corp. and its subsidiaries.  Fairway’s Chapter 11 has been recognized as the 2017 Consumer Staples Deal of the Year (Over $100 Million) by The M\u0026amp;A Advisor and the 2017 Turnaround Atlas Award for Pre-Pack Restructuring of the Year (Under $1 Billion) by Global M\u0026amp;A Network.  King \u0026amp; Spalding now serves as corporate counsel to Fairway post-restructuring.{{ FIELD }}Represented Modern Bank, N.A., as agent and lender, in providing a senior secured delayed draw term loan facility to The Smilist Management, Inc. to support its future purchase of dental practices.{{ FIELD }}Represented a steering committee of senior secured term lenders under a senior secured credit facility (and subsequent DIP and exit facilities) in the Chapter 11 cases of Boomerang Tube, LLC and its affiliates.{{ FIELD }}Represented General Electric Capital Corporation, as agent, in connection with a senior secured asset-based lending facility in favor of Brookstone Company, Inc., the proceeds of which financed, in part, Brookstone’s acquisition by affiliates of Chinese investment fund The Sanpower Group.{{ FIELD }}Represented Citizens Bank, National Association, as agent and lead arranger, in connection with a senior secured financing for a media company.{{ FIELD }}Represented General Electric Capital Corporation, as agent, in connection with a senior secured asset-based lending facility in favor of RadioShack Corporation.{{ FIELD }}Bryant Gatrell is a partner in our Corporate, Finance \u0026amp; Investments Practice Group.  He focuses his practice on the representation of financial institutions in leveraged, asset based and investment grade financings, as well as workouts and restructurings.  Bryant has extensive experience representing Fortune 50 financial institutions, private debt funds, BDC's, bondholders, lender groups, and other material stakeholders in complex financings throughout the capital structure, including unitranche and cross-border financings, in-court and out-of-court business reorganizations and debt restructurings. \nWith more than twenty-five years of experience, Bryant helps clients structure, negotiate and close financial transactions and restructurings in a wide array of industries, including telecom, media and technology, infrastructure, retail, restaurant, franchise and hospitality, healthcare and pharmaceutical, defense and aerospace, energy, transportation, commercial real estate and general industrial. Clients rely on his knowledge of the market and his commercial approach to closing deals to provide superior service to their customers in an increasingly competitive environment.  \nSome of Bryant’s recent significant representations include advising:  Antares Capital LP, as agent and lead arranger, in a $3,610,000,000 unitranche facility for a diversified insurance brokerage company; Webster Bank, N.A., as agent and lead arranger, in connection with Everstream Solutions, LLC’s purchase of fiber assets out of the Chapter 11 bankruptcy of Great Lakes Comnet and Comlink; Capital One, National Association, as agent, in connection with an asset based lending facility for an e-commerce company providing outdoor cooking and living products; Capital One, N.A., as agent and lead arranger, in connection with an asset based facility for bbq grill manufacturer; Golub Capital LLC, as agent and arranger, in connection with a secured credit facility to finance the acquisition of an addiction treatment company; Marathon Asset Management, Churchill Asset Management, MJX Asset Management and Allianz in connection with a super senior term loan to one of the largest car rental wholesale companies; Wells Fargo Bank, National Association, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers; a steering committee of term loan lenders of Vince, LLC; Goldman Sachs, Cerberus Capital Management, Arbour Lane Capital Management and other members of an ad hoc group of first lien and second lien lenders in an out-of-court restructuring of $450,000,000 in debt to a leading provider of visual marketing products for retailers, restaurants, movie studios and other entertainment companies, and medical service providers; U.S. Bank, N.A., as administrative agent and arranger, in connection a $3,750,000,000 vehicle floorplan facility for one of the largest automotive retailers in the United States; and Credit Suisse AG, Cayman Islands Branch, as agent, and a steering committee of senior secured lenders in the prepackaged Chapter 11 cases of Fairway Group Holdings Corp.\nPresentations, Speeches and Articles\nFranchise Times Finance and Growth Conference“Financial Covenants”“Middle Market Leveraged Finance Trends”“Middle Market Leveraged Finance”“Sponsors’ View of Term Sheets” Bryant Gatrell Partner Banking and Finance Law  The Best Lawyers in America, 2013–2017 University of Missouri-Columbia University of Missouri School of Law University of Michigan University of Michigan Law School North Carolina Represented Webster Bank, N.A., as agent and lead arranger, in providing senior secured credit facilities for the purchase by fiber network operator Everstream Solutions, LLC of the assets of Great Lakes Comnet and Comlink (GLC) out of GLC’s Chapter 11 bankruptcy. Represented Benefit Street Partners, LLC, as agent and lead arranger, in providing senior secured credit facilities to Inventure Foods Inc., a leading specialty food marketing and manufacturer. Represented Wells Fargo Bank, National Association, as agent and arranger, in providing senior secured credit facilities for a multi-state operator of television stations and newspapers. Represented GSO Capital Partners as a lender in the Chapter 11 cases of Roadhouse Holding Inc. (a/k/a Logan's Roadhouse) and its affiliated debtors.  During the Chapter 11 cases, Logan's successfully optimized its restaurant portfolio and substantially deleveraged its capital structure.  King \u0026amp; Spalding now serves as corporate counsel to Logan’s Roadhouse post-restructuring. Represented SunTrust Bank, as agent and arranger, in providing senior secured credit facilities for an outpatient radiology center company. Represented a steering committee of term loan lenders under the senior secured term loan facility in favor of Vince, LLC. Represented an investment fund in financing the acquisition by a private equity firm of a company providing drug and alcohol addiction treatment services. Represented Credit Suisse AG, Cayman Islands Branch, as agent under a senior secured credit facility (and subsequent DIP and exit facilities), and a steering committee of senior secured lenders, in the prepackaged chapter 11 cases of Fairway Group Holdings Corp. and its subsidiaries.  Fairway’s Chapter 11 has been recognized as the 2017 Consumer Staples Deal of the Year (Over $100 Million) by The M\u0026amp;A Advisor and the 2017 Turnaround Atlas Award for Pre-Pack Restructuring of the Year (Under $1 Billion) by Global M\u0026amp;A Network.  King \u0026amp; Spalding now serves as corporate counsel to Fairway post-restructuring. Represented Modern Bank, N.A., as agent and lender, in providing a senior secured delayed draw term loan facility to The Smilist Management, Inc. to support its future purchase of dental practices. Represented a steering committee of senior secured term lenders under a senior secured credit facility (and subsequent DIP and exit facilities) in the Chapter 11 cases of Boomerang Tube, LLC and its affiliates. Represented General Electric Capital Corporation, as agent, in connection with a senior secured asset-based lending facility in favor of Brookstone Company, Inc., the proceeds of which financed, in part, Brookstone’s acquisition by affiliates of Chinese investment fund The Sanpower Group. Represented Citizens Bank, National Association, as agent and lead arranger, in connection with a senior secured financing for a media company. Represented General Electric Capital Corporation, as agent, in connection with a senior secured asset-based lending facility in favor of RadioShack Corporation.","searchable_name":"Matthew Bryant Gatrell (Bryant)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":427193,"version":1,"owner_type":"Person","owner_id":6478,"payload":{"bio":"\u003cp\u003eChip Gaudreau has a broad range of experience defending multinational companies in complex product liability and mass tort litigations across multiple industries, with a particular focus on strategic litigation management and resolution strategies for the pharmaceutical, medical device and healthcare industries. Chip has also worked on national litigations involving automobiles, safety equipment, financial services and toxic torts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChip\u0026rsquo;s main focus is achieving the right outcome for clients in litigation. To that end, he provides all-inclusive strategic litigation management and resolution strategies that are narrowly tailored to clients\u0026rsquo; financial needs and ultimate goals. He manages and coordinates large teams in complex national litigation.\u003c/p\u003e\n\u003cp\u003eHe routinely designs and implements creative alternative fee arrangements and manages those arrangements during the life of an engagement to avoid surprises and provide predictability in \u0026ldquo;outside counsel\u0026rdquo; legal spend. In fact, Chip often works hand-in-hand with his clients and their legal finance departments to provide complete transparency in the level of work being performed and to ensure that expected financial targets are met.\u003c/p\u003e","slug":"russell-gaudreau","email":"rgaudreau@kslaw.com","phone":null,"matters":["\u003cp\u003eServes as national resolution counsel to an international medical device manufacturer in mesh and IVC filter multidistrict litigations.\u003c/p\u003e","\u003cp\u003eServes as resolution counsel to a pharmaceutical company in two separate multidistrict litigations.\u003c/p\u003e","\u003cp\u003eServed as coordinating and resolution counsel to a safety equipment manufacturer in defense of asbestos, CWP and silica claims pending in various state and federal courts across the country.\u003c/p\u003e","\u003cp\u003eServed as resolution counsel to a\u0026nbsp;\u003cem\u003eFortune\u003c/em\u003e\u0026nbsp;50 company in defense of foreign and domestic claims related to hip and knee implants.\u003c/p\u003e","\u003cp\u003eParticipated in the negotiation and ultimate settlement of the nation\u0026rsquo;s largest sales practice class action involving a Fortune 100 financial services company.\u003c/p\u003e","\u003cp\u003eServed as national coordinating counsel to one of the world\u0026rsquo;s largest pharmaceutical companies in its toxic tort litigation.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":6,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":7,"source":"smartTags"},{"id":762,"guid":"762.smart_tags","index":8,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":9,"source":"smartTags"}],"is_active":true,"last_name":"Gaudreau","nick_name":"Chip","clerkships":[{"name":"Law Clerk, Hon. Richard K. Eaton, U.S. Court of International Trade","years_held":"1998 - 2000"}],"first_name":"Russell","title_rank":9999,"updated_by":32,"law_schools":[{"id":1921,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"1998-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null},{"id":755,"meta":{"degree":"LL.M.","honors":"","is_law_school":"1","graduation_date":"1999-01-01 00:00:00"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"III","recognitions":[{"title":"Listed","detail":"The Legal 500 United States, Dispute Resolution - Product Liability, Mass Tort and Class Action - Pharmaceuticals and Medical Devices - Defense, 2018"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eChip Gaudreau has a broad range of experience defending multinational companies in complex product liability and mass tort litigations across multiple industries, with a particular focus on strategic litigation management and resolution strategies for the pharmaceutical, medical device and healthcare industries. Chip has also worked on national litigations involving automobiles, safety equipment, financial services and toxic torts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eChip\u0026rsquo;s main focus is achieving the right outcome for clients in litigation. To that end, he provides all-inclusive strategic litigation management and resolution strategies that are narrowly tailored to clients\u0026rsquo; financial needs and ultimate goals. He manages and coordinates large teams in complex national litigation.\u003c/p\u003e\n\u003cp\u003eHe routinely designs and implements creative alternative fee arrangements and manages those arrangements during the life of an engagement to avoid surprises and provide predictability in \u0026ldquo;outside counsel\u0026rdquo; legal spend. In fact, Chip often works hand-in-hand with his clients and their legal finance departments to provide complete transparency in the level of work being performed and to ensure that expected financial targets are met.\u003c/p\u003e","matters":["\u003cp\u003eServes as national resolution counsel to an international medical device manufacturer in mesh and IVC filter multidistrict litigations.\u003c/p\u003e","\u003cp\u003eServes as resolution counsel to a pharmaceutical company in two separate multidistrict litigations.\u003c/p\u003e","\u003cp\u003eServed as coordinating and resolution counsel to a safety equipment manufacturer in defense of asbestos, CWP and silica claims pending in various state and federal courts across the country.\u003c/p\u003e","\u003cp\u003eServed as resolution counsel to a\u0026nbsp;\u003cem\u003eFortune\u003c/em\u003e\u0026nbsp;50 company in defense of foreign and domestic claims related to hip and knee implants.\u003c/p\u003e","\u003cp\u003eParticipated in the negotiation and ultimate settlement of the nation\u0026rsquo;s largest sales practice class action involving a Fortune 100 financial services company.\u003c/p\u003e","\u003cp\u003eServed as national coordinating counsel to one of the world\u0026rsquo;s largest pharmaceutical companies in its toxic tort litigation.\u003c/p\u003e"],"recognitions":[{"title":"Listed","detail":"The Legal 500 United States, Dispute Resolution - Product Liability, Mass Tort and Class Action - Pharmaceuticals and Medical Devices - Defense, 2018"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10349}]},"capability_group_id":3},"created_at":"2025-05-26T04:59:11.000Z","updated_at":"2025-05-26T04:59:11.000Z","searchable_text":"Gaudreau{{ FIELD }}{:title=\u0026gt;\"Listed\", :detail=\u0026gt;\"The Legal 500 United States, Dispute Resolution - Product Liability, Mass Tort and Class Action - Pharmaceuticals and Medical Devices - Defense, 2018\"}{{ FIELD }}Serves as national resolution counsel to an international medical device manufacturer in mesh and IVC filter multidistrict litigations.{{ FIELD }}Serves as resolution counsel to a pharmaceutical company in two separate multidistrict litigations.{{ FIELD }}Served as coordinating and resolution counsel to a safety equipment manufacturer in defense of asbestos, CWP and silica claims pending in various state and federal courts across the country.{{ FIELD }}Served as resolution counsel to a Fortune 50 company in defense of foreign and domestic claims related to hip and knee implants.{{ FIELD }}Participated in the negotiation and ultimate settlement of the nation’s largest sales practice class action involving a Fortune 100 financial services company.{{ FIELD }}Served as national coordinating counsel to one of the world’s largest pharmaceutical companies in its toxic tort litigation.{{ FIELD }}Chip Gaudreau has a broad range of experience defending multinational companies in complex product liability and mass tort litigations across multiple industries, with a particular focus on strategic litigation management and resolution strategies for the pharmaceutical, medical device and healthcare industries. Chip has also worked on national litigations involving automobiles, safety equipment, financial services and toxic torts.\nChip’s main focus is achieving the right outcome for clients in litigation. To that end, he provides all-inclusive strategic litigation management and resolution strategies that are narrowly tailored to clients’ financial needs and ultimate goals. He manages and coordinates large teams in complex national litigation.\nHe routinely designs and implements creative alternative fee arrangements and manages those arrangements during the life of an engagement to avoid surprises and provide predictability in “outside counsel” legal spend. In fact, Chip often works hand-in-hand with his clients and their legal finance departments to provide complete transparency in the level of work being performed and to ensure that expected financial targets are met. Partner Listed The Legal 500 United States, Dispute Resolution - Product Liability, Mass Tort and Class Action - Pharmaceuticals and Medical Devices - Defense, 2018 Hobart William Smith Colleges  Suffolk University Suffolk University Law School Georgetown University Georgetown University Law Center Massachusetts New York Law Clerk, Hon. Richard K. Eaton, U.S. Court of International Trade Serves as national resolution counsel to an international medical device manufacturer in mesh and IVC filter multidistrict litigations. Serves as resolution counsel to a pharmaceutical company in two separate multidistrict litigations. Served as coordinating and resolution counsel to a safety equipment manufacturer in defense of asbestos, CWP and silica claims pending in various state and federal courts across the country. Served as resolution counsel to a Fortune 50 company in defense of foreign and domestic claims related to hip and knee implants. Participated in the negotiation and ultimate settlement of the nation’s largest sales practice class action involving a Fortune 100 financial services company. Served as national coordinating counsel to one of the world’s largest pharmaceutical companies in its toxic tort litigation.","searchable_name":"Russell Gaudreau III (Chip)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":445372,"version":1,"owner_type":"Person","owner_id":7298,"payload":{"bio":"\u003cp\u003eRachel Gilbert is a partner in the firm\u0026rsquo;s Healthcare practice and specializes in providing hospital systems with strategic reimbursement advice and advocacy. Rachel\u0026rsquo;s experience includes designing and implementing new supplemental Medicaid payment programs, optimizing participation in existing Medicaid and Medicare programs, advising on federal and state compliance issues, and litigating payer-provider disputes with health plans across products. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRachel\u0026rsquo;s legal practice focuses on advising hospitals in reimbursement, regulatory, legislative, and operational business matters.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn the Medicaid space, Rachel works on behalf of her clients in collaboration with industry and government stakeholders to design, implement, and finance Medicaid supplemental reimbursement programs. Rachel represents investor-owned, non-profit, and governmental hospitals, ranging from large acute care systems, freestanding children\u0026rsquo;s hospitals, and freestanding psychiatric hospitals. In addition to advocating for new or improved payment programs, Rachel works with hospitals to optimize their participation in existing reimbursement programs within dozens of states, including Medicaid Disproportionate Share Hospital programs, waiver programs, and state directed payment programs.\u003c/p\u003e\n\u003cp\u003eRachel also represents hospitals in complex payment and contract disputes. Rachel has represented numerous providers in disputes with Medicare Advantage plans and Medicaid managed care organizations, on issues ranging from underpayments, overpayments, denials, slow-pays, and compliance with federal and state regulatory requirements. Rachel has also represented providers under investigation by state and federal agencies for issues ranging from False Claims Act violations, violation of the federal IMD exclusion, and other billing and reimbursement related audits and allegations.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eRachel enjoys partnering with clients to compliantly develop and implement hospital financial strategies. Rachel is well-versed in various forms of advocacy for her clients, such as developing talking points for C-suite executives, drafting proposed laws and regulations, performing complex financial modeling in support of client proposals, and facilitating industry coalitions to advocate for improved access to reimbursement before state and federal lawmakers.\u003c/p\u003e","slug":"rachel-gilbert","email":"rgilbert@kslaw.com","phone":null,"matters":["\u003cp\u003eAdvised the \u003cstrong\u003eChildren\u0026rsquo;s Hospital Association of Texas (CHAT)\u003c/strong\u003e for several years on a variety of Medicaid reimbursement issues. For example, Rachel assisted CHAT in successfully advocating to the Texas Medicaid agency \u003cstrong\u003e\u003cem\u003etwice\u003c/em\u003e\u003c/strong\u003e in the past two years to change course and preserve more than $1 billion in annual reimbursements to CHAT\u0026rsquo;s members.\u003c/p\u003e","\u003cp\u003eAdvocated to the Governor\u0026rsquo;s Office, Legislature, and Medicaid agency in numerous states to gain entry into Medicaid state directed payment programs for \u003cstrong\u003efreestanding psychiatric hospitals\u003c/strong\u003e, which have historically been excluded from most (if not all) supplemental Medicaid payment programs.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresents a number of \u003cstrong\u003enonprofit and governmental hospitals\u003c/strong\u003e in arbitrations against Medicare Advantage plans for 340B underpayments that occurred nationwide from 2018-2022. Most recently, Rachel won a multi-million-dollar arbitration award for a non-profit hospital system and won summary judgment on the issue of liability for state hospital system.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":740,"guid":"740.smart_tags","index":4,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":5,"source":"smartTags"}],"is_active":true,"last_name":"Gilbert","nick_name":"Rachel","clerkships":[],"first_name":"Rachel","title_rank":9999,"updated_by":34,"law_schools":[{"id":2055,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null},{"id":3160,"meta":{"degree":"LL.M., International Law","honors":"with distinction","is_law_school":"1","graduation_date":"2011-01-01 00:00:00"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":"O.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/rachel-o-gilbert/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eRachel Gilbert is a partner in the firm\u0026rsquo;s Healthcare practice and specializes in providing hospital systems with strategic reimbursement advice and advocacy. Rachel\u0026rsquo;s experience includes designing and implementing new supplemental Medicaid payment programs, optimizing participation in existing Medicaid and Medicare programs, advising on federal and state compliance issues, and litigating payer-provider disputes with health plans across products. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eRachel\u0026rsquo;s legal practice focuses on advising hospitals in reimbursement, regulatory, legislative, and operational business matters.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eIn the Medicaid space, Rachel works on behalf of her clients in collaboration with industry and government stakeholders to design, implement, and finance Medicaid supplemental reimbursement programs. Rachel represents investor-owned, non-profit, and governmental hospitals, ranging from large acute care systems, freestanding children\u0026rsquo;s hospitals, and freestanding psychiatric hospitals. In addition to advocating for new or improved payment programs, Rachel works with hospitals to optimize their participation in existing reimbursement programs within dozens of states, including Medicaid Disproportionate Share Hospital programs, waiver programs, and state directed payment programs.\u003c/p\u003e\n\u003cp\u003eRachel also represents hospitals in complex payment and contract disputes. Rachel has represented numerous providers in disputes with Medicare Advantage plans and Medicaid managed care organizations, on issues ranging from underpayments, overpayments, denials, slow-pays, and compliance with federal and state regulatory requirements. Rachel has also represented providers under investigation by state and federal agencies for issues ranging from False Claims Act violations, violation of the federal IMD exclusion, and other billing and reimbursement related audits and allegations.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eRachel enjoys partnering with clients to compliantly develop and implement hospital financial strategies. Rachel is well-versed in various forms of advocacy for her clients, such as developing talking points for C-suite executives, drafting proposed laws and regulations, performing complex financial modeling in support of client proposals, and facilitating industry coalitions to advocate for improved access to reimbursement before state and federal lawmakers.\u003c/p\u003e","matters":["\u003cp\u003eAdvised the \u003cstrong\u003eChildren\u0026rsquo;s Hospital Association of Texas (CHAT)\u003c/strong\u003e for several years on a variety of Medicaid reimbursement issues. For example, Rachel assisted CHAT in successfully advocating to the Texas Medicaid agency \u003cstrong\u003e\u003cem\u003etwice\u003c/em\u003e\u003c/strong\u003e in the past two years to change course and preserve more than $1 billion in annual reimbursements to CHAT\u0026rsquo;s members.\u003c/p\u003e","\u003cp\u003eAdvocated to the Governor\u0026rsquo;s Office, Legislature, and Medicaid agency in numerous states to gain entry into Medicaid state directed payment programs for \u003cstrong\u003efreestanding psychiatric hospitals\u003c/strong\u003e, which have historically been excluded from most (if not all) supplemental Medicaid payment programs.\u0026nbsp;\u003c/p\u003e","\u003cp\u003eRepresents a number of \u003cstrong\u003enonprofit and governmental hospitals\u003c/strong\u003e in arbitrations against Medicare Advantage plans for 340B underpayments that occurred nationwide from 2018-2022. Most recently, Rachel won a multi-million-dollar arbitration award for a non-profit hospital system and won summary judgment on the issue of liability for state hospital system.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13318}]},"capability_group_id":2},"created_at":"2026-01-30T05:02:47.000Z","updated_at":"2026-01-30T05:02:47.000Z","searchable_text":"Gilbert{{ FIELD }}Advised the Children’s Hospital Association of Texas (CHAT) for several years on a variety of Medicaid reimbursement issues. For example, Rachel assisted CHAT in successfully advocating to the Texas Medicaid agency twice in the past two years to change course and preserve more than $1 billion in annual reimbursements to CHAT’s members.{{ FIELD }}Advocated to the Governor’s Office, Legislature, and Medicaid agency in numerous states to gain entry into Medicaid state directed payment programs for freestanding psychiatric hospitals, which have historically been excluded from most (if not all) supplemental Medicaid payment programs. {{ FIELD }}Represents a number of nonprofit and governmental hospitals in arbitrations against Medicare Advantage plans for 340B underpayments that occurred nationwide from 2018-2022. Most recently, Rachel won a multi-million-dollar arbitration award for a non-profit hospital system and won summary judgment on the issue of liability for state hospital system.{{ FIELD }}Rachel Gilbert is a partner in the firm’s Healthcare practice and specializes in providing hospital systems with strategic reimbursement advice and advocacy. Rachel’s experience includes designing and implementing new supplemental Medicaid payment programs, optimizing participation in existing Medicaid and Medicare programs, advising on federal and state compliance issues, and litigating payer-provider disputes with health plans across products. \nRachel’s legal practice focuses on advising hospitals in reimbursement, regulatory, legislative, and operational business matters. \nIn the Medicaid space, Rachel works on behalf of her clients in collaboration with industry and government stakeholders to design, implement, and finance Medicaid supplemental reimbursement programs. Rachel represents investor-owned, non-profit, and governmental hospitals, ranging from large acute care systems, freestanding children’s hospitals, and freestanding psychiatric hospitals. In addition to advocating for new or improved payment programs, Rachel works with hospitals to optimize their participation in existing reimbursement programs within dozens of states, including Medicaid Disproportionate Share Hospital programs, waiver programs, and state directed payment programs.\nRachel also represents hospitals in complex payment and contract disputes. Rachel has represented numerous providers in disputes with Medicare Advantage plans and Medicaid managed care organizations, on issues ranging from underpayments, overpayments, denials, slow-pays, and compliance with federal and state regulatory requirements. Rachel has also represented providers under investigation by state and federal agencies for issues ranging from False Claims Act violations, violation of the federal IMD exclusion, and other billing and reimbursement related audits and allegations. \nRachel enjoys partnering with clients to compliantly develop and implement hospital financial strategies. Rachel is well-versed in various forms of advocacy for her clients, such as developing talking points for C-suite executives, drafting proposed laws and regulations, performing complex financial modeling in support of client proposals, and facilitating industry coalitions to advocate for improved access to reimbursement before state and federal lawmakers. Partner North Carolina State University  The University of Texas at Austin The University of Texas School of Law The University of Edinburgh Edinburgh Law School North Carolina South Carolina Texas Advised the Children’s Hospital Association of Texas (CHAT) for several years on a variety of Medicaid reimbursement issues. For example, Rachel assisted CHAT in successfully advocating to the Texas Medicaid agency twice in the past two years to change course and preserve more than $1 billion in annual reimbursements to CHAT’s members. Advocated to the Governor’s Office, Legislature, and Medicaid agency in numerous states to gain entry into Medicaid state directed payment programs for freestanding psychiatric hospitals, which have historically been excluded from most (if not all) supplemental Medicaid payment programs.  Represents a number of nonprofit and governmental hospitals in arbitrations against Medicare Advantage plans for 340B underpayments that occurred nationwide from 2018-2022. Most recently, Rachel won a multi-million-dollar arbitration award for a non-profit hospital system and won summary judgment on the issue of liability for state hospital system.","searchable_name":"Rachel O. Gilbert","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":430228,"version":1,"owner_type":"Person","owner_id":551,"payload":{"bio":"\u003cp\u003eBrent Gilfedder specializes in structuring and executing real estate investments and transactions. A partner in our Real Estate practice, Brent represents a variety of sponsors and investors in all types of real estate development, investment and financing matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBrent advises private equity institutions, equity investors and developers-sponsors in all aspects of their real estate business, as well as the structuring of joint ventures and advising real estate investment trusts. He focuses particularly on structuring real estate equity investments, development transactions, acquisitions and dispositions, and financings.\u003c/p\u003e\n\u003cp\u003eBefore studying law, Brent earned a Masters in Taxation from the University of Denver, and previously worked as a tax accountant for KPMG.\u003c/p\u003e\n\u003cp\u003eBrent is a published author on real estate financial topics. He has been recognized by Georgia\u0026nbsp;\u003cem\u003eSuper Lawyers\u003c/em\u003e\u0026nbsp;as a 2013\u0026ndash;2016 Rising Star, and in 2015 by\u0026nbsp;\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;for Real Estate and Construction.\u003c/p\u003e","slug":"brent-gilfedder","email":"bgilfedder@kslaw.com","phone":null,"matters":["\u003cp\u003eActed as outside fund general counsel for\u0026nbsp;\u003cstrong\u003eMorgan Stanley'\u003c/strong\u003e\u003cstrong\u003es Prime Property Fund,\u003c/strong\u003e\u0026nbsp;a market-leading open-end fund with over $38 billion in real estate assets. Also represent Prime in a majority of their transactions. Transactions include dozens of investments, ventures and financings in office, retail, hotel, industrial and apartment projects located in all U.S. regions for in excess of $15 billion.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMorgan Stanley's Prime Property Fund\u0026nbsp;\u003c/strong\u003ein a $5.5 billion programmatic joint venture for student housing assets with GSA, including the initial acquisition of two portfolios for $1.8 billion across the United States.\u003c/p\u003e","\u003cp\u003eRepresent leading developer\u0026nbsp;\u003cstrong\u003eNovare Group\u003c/strong\u003e\u0026nbsp;in connection with all of its multifamily and mixed use developments across the United States, including, acquisition, joint venture, development matters, financing and dispositions of multifamily assets in Georgia, North Carolina, South Carolina, Florida, Texas, Alabama, Colorado, Tennessee, Virginia. Project values have totaled in excess of $2 billion and over 15 projects.\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGeorgia State University\u003c/strong\u003e\u0026nbsp;in connection with its partnership with Carter to acquire and re-develop Turner Field in Atlanta, Georgia into the home of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGeorgia State\u003c/strong\u003e\u0026nbsp;football and a large mixed-use development.\u003c/p\u003e","\u003cp\u003eLed the representation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eCousins Properties\u003c/strong\u003e\u0026nbsp;in connection with their acquisition and development of the world headquarters for NCR Corporation in Midtown Atlanta, a project in excess of $300 million which involved acquisition, development, governmental incentives and master lease issues.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eBatson-Cook Development Company\u003c/strong\u003e\u0026nbsp;in connection with all of its joint ventures and development transactions across the United States.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eVentas, Inc.\u003c/strong\u003e\u0026nbsp;in connection with a joint venture with GIC Private Limited for the development of five life science projects for total development costs in excess of $1 billion.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eAtlanta multifamily operator and developer\u003c/strong\u003e\u0026nbsp;in the acquisition of over $200 million of multifamily communities and over $250 million in development projects, including negotiation of joint ventures with institutional equity partners such as AIG, Alliance Bernstein and Carlyle.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eretail operator\u003c/strong\u003e\u0026nbsp;in connection with their $400 million programmatic joint venture with institutional investor and the acquisition of seven seed assets.\u003c/p\u003e","\u003cp\u003eAcquisition of 50% joint venture interest on behalf of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ean\u003c/strong\u003e\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einstitutional REIT investor\u003c/strong\u003e\u0026nbsp;for $450 million downtown Boston mixed-use asset.\u003c/p\u003e","\u003cp\u003eRepresent national student housing developer\u0026nbsp;\u003cstrong\u003eLandmark Properties\u003c/strong\u003e\u0026nbsp;in connection with over a dozen student-housing developments at colleges across the United States with an aggregate value of over $500 million.\u003c/p\u003e","\u003cp\u003eLead the representation of all of\u0026nbsp;\u003cstrong\u003ePenler's\u003c/strong\u003e\u0026nbsp;multifamily developments across the Southeast US, including approximately 6 projects in Georgia, Florida, South Carolina and Tennessee, including, joint ventures with institutional investors, financing, acquisition, development and disposition.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ean\u003c/strong\u003e\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einstitutional REIT operator\u003c/strong\u003e\u0026nbsp;in $500 million joint venture with Canadian governmental pension plan for development and acquisition of Class A multifamily assets.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eClarion Partners\u003c/strong\u003e\u0026nbsp;in connection with the acquisition of existing and development projects by its Qualified Opportunity Zone Fund, including, joint ventures, development and financing for office, multifamily and industrial assets.\u003c/p\u003e","\u003cp\u003eFormation of $400 million real estate investment fund for commercial office properties.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":84}]},"expertise":[{"id":26,"guid":"26.capabilities","index":0,"source":"capabilities"},{"id":35,"guid":"35.capabilities","index":1,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":2,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":5,"source":"capabilities"},{"id":36,"guid":"36.capabilities","index":6,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":7,"source":"capabilities"},{"id":109,"guid":"109.capabilities","index":8,"source":"capabilities"},{"id":115,"guid":"115.capabilities","index":9,"source":"capabilities"},{"id":1140,"guid":"1140.smart_tags","index":10,"source":"smartTags"},{"id":80,"guid":"80.capabilities","index":11,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":12,"source":"capabilities"},{"id":1255,"guid":"1255.smart_tags","index":13,"source":"smartTags"},{"id":1261,"guid":"1261.smart_tags","index":14,"source":"smartTags"},{"id":1434,"guid":"1434.smart_tags","index":15,"source":"smartTags"}],"is_active":true,"last_name":"Gilfedder","nick_name":"Brent","clerkships":[],"first_name":"Brent","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"S.","name_suffix":"","recognitions":[{"title":"Band 2 for Georgia Real Estate ","detail":"Chambers USA 2025"},{"title":"On the Rise (one of 25 lawyers under the age of 40 selected from Atlanta) ","detail":"Daily Report, 2016"},{"title":"Georgia Rising Star","detail":"Super Lawyers, 2013–2016"}],"linked_in_url":"https://www.linkedin.com/in/brent-gilfedder-1823561a/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eBrent Gilfedder specializes in structuring and executing real estate investments and transactions. A partner in our Real Estate practice, Brent represents a variety of sponsors and investors in all types of real estate development, investment and financing matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBrent advises private equity institutions, equity investors and developers-sponsors in all aspects of their real estate business, as well as the structuring of joint ventures and advising real estate investment trusts. He focuses particularly on structuring real estate equity investments, development transactions, acquisitions and dispositions, and financings.\u003c/p\u003e\n\u003cp\u003eBefore studying law, Brent earned a Masters in Taxation from the University of Denver, and previously worked as a tax accountant for KPMG.\u003c/p\u003e\n\u003cp\u003eBrent is a published author on real estate financial topics. He has been recognized by Georgia\u0026nbsp;\u003cem\u003eSuper Lawyers\u003c/em\u003e\u0026nbsp;as a 2013\u0026ndash;2016 Rising Star, and in 2015 by\u0026nbsp;\u003cem\u003eLegal 500\u003c/em\u003e\u0026nbsp;for Real Estate and Construction.\u003c/p\u003e","matters":["\u003cp\u003eActed as outside fund general counsel for\u0026nbsp;\u003cstrong\u003eMorgan Stanley'\u003c/strong\u003e\u003cstrong\u003es Prime Property Fund,\u003c/strong\u003e\u0026nbsp;a market-leading open-end fund with over $38 billion in real estate assets. Also represent Prime in a majority of their transactions. Transactions include dozens of investments, ventures and financings in office, retail, hotel, industrial and apartment projects located in all U.S. regions for in excess of $15 billion.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eMorgan Stanley's Prime Property Fund\u0026nbsp;\u003c/strong\u003ein a $5.5 billion programmatic joint venture for student housing assets with GSA, including the initial acquisition of two portfolios for $1.8 billion across the United States.\u003c/p\u003e","\u003cp\u003eRepresent leading developer\u0026nbsp;\u003cstrong\u003eNovare Group\u003c/strong\u003e\u0026nbsp;in connection with all of its multifamily and mixed use developments across the United States, including, acquisition, joint venture, development matters, financing and dispositions of multifamily assets in Georgia, North Carolina, South Carolina, Florida, Texas, Alabama, Colorado, Tennessee, Virginia. Project values have totaled in excess of $2 billion and over 15 projects.\u003c/p\u003e","\u003cp\u003eAdvised\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGeorgia State University\u003c/strong\u003e\u0026nbsp;in connection with its partnership with Carter to acquire and re-develop Turner Field in Atlanta, Georgia into the home of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eGeorgia State\u003c/strong\u003e\u0026nbsp;football and a large mixed-use development.\u003c/p\u003e","\u003cp\u003eLed the representation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eCousins Properties\u003c/strong\u003e\u0026nbsp;in connection with their acquisition and development of the world headquarters for NCR Corporation in Midtown Atlanta, a project in excess of $300 million which involved acquisition, development, governmental incentives and master lease issues.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eBatson-Cook Development Company\u003c/strong\u003e\u0026nbsp;in connection with all of its joint ventures and development transactions across the United States.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong\u003eVentas, Inc.\u003c/strong\u003e\u0026nbsp;in connection with a joint venture with GIC Private Limited for the development of five life science projects for total development costs in excess of $1 billion.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eAtlanta multifamily operator and developer\u003c/strong\u003e\u0026nbsp;in the acquisition of over $200 million of multifamily communities and over $250 million in development projects, including negotiation of joint ventures with institutional equity partners such as AIG, Alliance Bernstein and Carlyle.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea\u003c/strong\u003e\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eretail operator\u003c/strong\u003e\u0026nbsp;in connection with their $400 million programmatic joint venture with institutional investor and the acquisition of seven seed assets.\u003c/p\u003e","\u003cp\u003eAcquisition of 50% joint venture interest on behalf of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ean\u003c/strong\u003e\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einstitutional REIT investor\u003c/strong\u003e\u0026nbsp;for $450 million downtown Boston mixed-use asset.\u003c/p\u003e","\u003cp\u003eRepresent national student housing developer\u0026nbsp;\u003cstrong\u003eLandmark Properties\u003c/strong\u003e\u0026nbsp;in connection with over a dozen student-housing developments at colleges across the United States with an aggregate value of over $500 million.\u003c/p\u003e","\u003cp\u003eLead the representation of all of\u0026nbsp;\u003cstrong\u003ePenler's\u003c/strong\u003e\u0026nbsp;multifamily developments across the Southeast US, including approximately 6 projects in Georgia, Florida, South Carolina and Tennessee, including, joint ventures with institutional investors, financing, acquisition, development and disposition.\u003c/p\u003e","\u003cp\u003eRepresented\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ean\u003c/strong\u003e\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einstitutional REIT operator\u003c/strong\u003e\u0026nbsp;in $500 million joint venture with Canadian governmental pension plan for development and acquisition of Class A multifamily assets.\u003c/p\u003e","\u003cp\u003eRepresent\u0026nbsp;\u003cstrong\u003eClarion Partners\u003c/strong\u003e\u0026nbsp;in connection with the acquisition of existing and development projects by its Qualified Opportunity Zone Fund, including, joint ventures, development and financing for office, multifamily and industrial assets.\u003c/p\u003e","\u003cp\u003eFormation of $400 million real estate investment fund for commercial office properties.\u003c/p\u003e"],"recognitions":[{"title":"Band 2 for Georgia Real Estate ","detail":"Chambers USA 2025"},{"title":"On the Rise (one of 25 lawyers under the age of 40 selected from Atlanta) ","detail":"Daily Report, 2016"},{"title":"Georgia Rising Star","detail":"Super Lawyers, 2013–2016"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12848}]},"capability_group_id":1},"created_at":"2025-06-13T20:28:04.000Z","updated_at":"2025-06-13T20:28:04.000Z","searchable_text":"Gilfedder{{ FIELD }}{:title=\u0026gt;\"Band 2 for Georgia Real Estate \", :detail=\u0026gt;\"Chambers USA 2025\"}{{ FIELD }}{:title=\u0026gt;\"On the Rise (one of 25 lawyers under the age of 40 selected from Atlanta) \", :detail=\u0026gt;\"Daily Report, 2016\"}{{ FIELD }}{:title=\u0026gt;\"Georgia Rising Star\", :detail=\u0026gt;\"Super Lawyers, 2013–2016\"}{{ FIELD }}Acted as outside fund general counsel for Morgan Stanley's Prime Property Fund, a market-leading open-end fund with over $38 billion in real estate assets. Also represent Prime in a majority of their transactions. Transactions include dozens of investments, ventures and financings in office, retail, hotel, industrial and apartment projects located in all U.S. regions for in excess of $15 billion.{{ FIELD }}Represented Morgan Stanley's Prime Property Fund in a $5.5 billion programmatic joint venture for student housing assets with GSA, including the initial acquisition of two portfolios for $1.8 billion across the United States.{{ FIELD }}Represent leading developer Novare Group in connection with all of its multifamily and mixed use developments across the United States, including, acquisition, joint venture, development matters, financing and dispositions of multifamily assets in Georgia, North Carolina, South Carolina, Florida, Texas, Alabama, Colorado, Tennessee, Virginia. Project values have totaled in excess of $2 billion and over 15 projects.{{ FIELD }}Advised Georgia State University in connection with its partnership with Carter to acquire and re-develop Turner Field in Atlanta, Georgia into the home of Georgia State football and a large mixed-use development.{{ FIELD }}Led the representation of Cousins Properties in connection with their acquisition and development of the world headquarters for NCR Corporation in Midtown Atlanta, a project in excess of $300 million which involved acquisition, development, governmental incentives and master lease issues.{{ FIELD }}Represent Batson-Cook Development Company in connection with all of its joint ventures and development transactions across the United States.{{ FIELD }}Represented Ventas, Inc. in connection with a joint venture with GIC Private Limited for the development of five life science projects for total development costs in excess of $1 billion.{{ FIELD }}Represent Atlanta multifamily operator and developer in the acquisition of over $200 million of multifamily communities and over $250 million in development projects, including negotiation of joint ventures with institutional equity partners such as AIG, Alliance Bernstein and Carlyle.{{ FIELD }}Represent a retail operator in connection with their $400 million programmatic joint venture with institutional investor and the acquisition of seven seed assets.{{ FIELD }}Acquisition of 50% joint venture interest on behalf of an institutional REIT investor for $450 million downtown Boston mixed-use asset.{{ FIELD }}Represent national student housing developer Landmark Properties in connection with over a dozen student-housing developments at colleges across the United States with an aggregate value of over $500 million.{{ FIELD }}Lead the representation of all of Penler's multifamily developments across the Southeast US, including approximately 6 projects in Georgia, Florida, South Carolina and Tennessee, including, joint ventures with institutional investors, financing, acquisition, development and disposition.{{ FIELD }}Represented an institutional REIT operator in $500 million joint venture with Canadian governmental pension plan for development and acquisition of Class A multifamily assets.{{ FIELD }}Represent Clarion Partners in connection with the acquisition of existing and development projects by its Qualified Opportunity Zone Fund, including, joint ventures, development and financing for office, multifamily and industrial assets.{{ FIELD }}Formation of $400 million real estate investment fund for commercial office properties.{{ FIELD }}Brent Gilfedder specializes in structuring and executing real estate investments and transactions. A partner in our Real Estate practice, Brent represents a variety of sponsors and investors in all types of real estate development, investment and financing matters.\nBrent advises private equity institutions, equity investors and developers-sponsors in all aspects of their real estate business, as well as the structuring of joint ventures and advising real estate investment trusts. He focuses particularly on structuring real estate equity investments, development transactions, acquisitions and dispositions, and financings.\nBefore studying law, Brent earned a Masters in Taxation from the University of Denver, and previously worked as a tax accountant for KPMG.\nBrent is a published author on real estate financial topics. He has been recognized by Georgia Super Lawyers as a 2013–2016 Rising Star, and in 2015 by Legal 500 for Real Estate and Construction. Brent S Gilfedder Partner Band 2 for Georgia Real Estate  Chambers USA 2025 On the Rise (one of 25 lawyers under the age of 40 selected from Atlanta)  Daily Report, 2016 Georgia Rising Star Super Lawyers, 2013–2016 Transylvania University  University of Georgia University of Georgia School of Law University of Denver Sturm College of Law Georgia Acted as outside fund general counsel for Morgan Stanley's Prime Property Fund, a market-leading open-end fund with over $38 billion in real estate assets. Also represent Prime in a majority of their transactions. Transactions include dozens of investments, ventures and financings in office, retail, hotel, industrial and apartment projects located in all U.S. regions for in excess of $15 billion. Represented Morgan Stanley's Prime Property Fund in a $5.5 billion programmatic joint venture for student housing assets with GSA, including the initial acquisition of two portfolios for $1.8 billion across the United States. Represent leading developer Novare Group in connection with all of its multifamily and mixed use developments across the United States, including, acquisition, joint venture, development matters, financing and dispositions of multifamily assets in Georgia, North Carolina, South Carolina, Florida, Texas, Alabama, Colorado, Tennessee, Virginia. Project values have totaled in excess of $2 billion and over 15 projects. Advised Georgia State University in connection with its partnership with Carter to acquire and re-develop Turner Field in Atlanta, Georgia into the home of Georgia State football and a large mixed-use development. Led the representation of Cousins Properties in connection with their acquisition and development of the world headquarters for NCR Corporation in Midtown Atlanta, a project in excess of $300 million which involved acquisition, development, governmental incentives and master lease issues. Represent Batson-Cook Development Company in connection with all of its joint ventures and development transactions across the United States. Represented Ventas, Inc. in connection with a joint venture with GIC Private Limited for the development of five life science projects for total development costs in excess of $1 billion. Represent Atlanta multifamily operator and developer in the acquisition of over $200 million of multifamily communities and over $250 million in development projects, including negotiation of joint ventures with institutional equity partners such as AIG, Alliance Bernstein and Carlyle. Represent a retail operator in connection with their $400 million programmatic joint venture with institutional investor and the acquisition of seven seed assets. Acquisition of 50% joint venture interest on behalf of an institutional REIT investor for $450 million downtown Boston mixed-use asset. Represent national student housing developer Landmark Properties in connection with over a dozen student-housing developments at colleges across the United States with an aggregate value of over $500 million. Lead the representation of all of Penler's multifamily developments across the Southeast US, including approximately 6 projects in Georgia, Florida, South Carolina and Tennessee, including, joint ventures with institutional investors, financing, acquisition, development and disposition. Represented an institutional REIT operator in $500 million joint venture with Canadian governmental pension plan for development and acquisition of Class A multifamily assets. Represent Clarion Partners in connection with the acquisition of existing and development projects by its Qualified Opportunity Zone Fund, including, joint ventures, development and financing for office, multifamily and industrial assets. Formation of $400 million real estate investment fund for commercial office properties.","searchable_name":"Brent S. Gilfedder","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445370,"version":1,"owner_type":"Person","owner_id":7296,"payload":{"bio":"\u003cp\u003eJim Gilliam is a partner in the firm\u0026rsquo;s Healthcare practice. Jim\u0026rsquo;s practice is focused on healthcare litigation. Jim\u0026rsquo;s capabilities include commercial and government managed care, complex business litigation, arbitration, mediation, class/collective actions, investigations, and appellate advocacy.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJim represents healthcare providers in a variety of business disputes, on issues ranging from government and commercial reimbursement, misappropriation of hospital proprietary information, and post-M\u0026amp;A disputes. Jim also represents healthcare providers in government investigations, including allegations of Medicaid and Medicare billing fraud and federal/state compliance audits. Jim uses his depth and breadth of experience to assist healthcare providers in navigating a heavily regulated and complex business environment.\u003c/p\u003e\n\u003cp\u003eJim has significant courtroom experience, having tried numerous cases and argued multiple appeals. In addition to his healthcare practice, Jim has represented governmental entities and educational institutions on marquis litigations over the course of his career. One of Jim\u0026rsquo;s more noteworthy representations includes successfully representing a large public institution in a five-day federal jury trial involving Title IX of the Education Amendments of 1972. This was the first trial of its kind in the country.\u003c/p\u003e\n\u003cp\u003eAdditionally, Jim has argued before the Supreme Court of South Carolina on several high-profile issues. As lead counsel for the Speaker of the House of Representatives, Jim successfully defended the constitutionality of The Heritage Act, which removed the Confederate flag from the dome of the State House. Also, as lead counsel for the Speaker of the House of Representatives, Jim successfully defended the constitutionality of legislation allowing counties and cities to impose service fees. Most recently, as lead counsel for the Speaker of the House of Representatives, Jim argued in defense of School Choice legislation.\u003c/p\u003e\n\u003cp\u003ePrior to private practice, Jim clerked for the Honorable Kaye G. Hearn at the South Carolina of Appeals and South Carolina Supreme Court.\u003c/p\u003e","slug":"james-gilliam","email":"jgilliam@kslaw.com","phone":null,"matters":["\u003cp\u003eServed as co-lead counsel for a \u003cstrong\u003elarge hospital system\u003c/strong\u003e in an arbitration against a large Medicare Advantage company, obtaining a multi-million-dollar award in 2025 for 340B underpayments from 2018-2022.\u003c/p\u003e","\u003cp\u003eCurrently serving as co-lead counsel for several \u003cstrong\u003enon-profit and governmental hospital systems\u003c/strong\u003e on in Medicare Advantage-340B disputes. 340B hospitals across the country were harmed to the tune of billions of dollars as a result of Medicare Advantage plans passing through and refusing to remediate an unlawful Medicare rate they paid to 340B hospitals from 2018-2022.\u003c/p\u003e","\u003cp\u003eServed as co-lead counsel for a \u003cstrong\u003elarge state university hospital system\u003c/strong\u003e in a litigation against a departing physician group, obtaining a high-dollar settlement for misappropriation of hospital proprietary information and trade secrets. This case was important to the hospital in protecting its ability to invest in innovative service lines without fear of competitors \u0026ldquo;jumping the line\u0026rdquo; by poaching the hospital\u0026rsquo;s employees and playbook.\u003c/p\u003e","\u003cp\u003eServed as lead counsel for the \u003cstrong\u003eSpeaker of the South Carolina House of Representatives\u003c/strong\u003e in the \u0026ldquo;Heritage Act case\u0026rdquo; commenced in the original jurisdiction of the South Carolina Supreme Court. After briefing and oral argument in support of the Heritage Act, which removed the Confederate Flag from the State House grounds, the Supreme Court upheld its constitutionality.\u003c/p\u003e","\u003cp\u003eServed as lead counsel for \u003cstrong\u003eCoastal Carolina University\u003c/strong\u003e in a Title IX student discipline case tried in front of a jury before the United States District Court for the District of South Carolina and obtained a defense verdict. This was the first student discipline case tried to a jury in the country.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"}],"is_active":true,"last_name":"Gilliam","nick_name":"Jim","clerkships":[{"name":"Law Clerk, Honorable Kaye G. Hearn, Chief Judge, South Carolina Court of Appeals","years_held":"2008 - 2009"},{"name":"Law Clerk, Honorable Kaye G. Hearn, Associate Justice, South Carolina Supreme Court","years_held":"2009 - 2010"}],"first_name":"James","title_rank":9999,"updated_by":34,"law_schools":[{"id":2910,"meta":{"degree":"J.D.","honors":"magna cum laude","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"K.","name_suffix":"","recognitions":[{"title":"\"Up and Coming,\" Labor \u0026 Employment","detail":"Chambers USA, 2022-2024"},{"title":"Martindale-Hubbell AV Preeminent Peer Review Rating","detail":""},{"title":"Ones to Watch in America, Labor \u0026 Employment","detail":"Best Lawyers, 2021"},{"title":"“Rising Star,” Labor \u0026 Employment","detail":"South Carolina Super Lawyers, 2014-2022"},{"title":"“Legal Elite,” Business Litigation","detail":"Greenville Business Magazine, 2021, 2023"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJim Gilliam is a partner in the firm\u0026rsquo;s Healthcare practice. Jim\u0026rsquo;s practice is focused on healthcare litigation. Jim\u0026rsquo;s capabilities include commercial and government managed care, complex business litigation, arbitration, mediation, class/collective actions, investigations, and appellate advocacy.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJim represents healthcare providers in a variety of business disputes, on issues ranging from government and commercial reimbursement, misappropriation of hospital proprietary information, and post-M\u0026amp;A disputes. Jim also represents healthcare providers in government investigations, including allegations of Medicaid and Medicare billing fraud and federal/state compliance audits. Jim uses his depth and breadth of experience to assist healthcare providers in navigating a heavily regulated and complex business environment.\u003c/p\u003e\n\u003cp\u003eJim has significant courtroom experience, having tried numerous cases and argued multiple appeals. In addition to his healthcare practice, Jim has represented governmental entities and educational institutions on marquis litigations over the course of his career. One of Jim\u0026rsquo;s more noteworthy representations includes successfully representing a large public institution in a five-day federal jury trial involving Title IX of the Education Amendments of 1972. This was the first trial of its kind in the country.\u003c/p\u003e\n\u003cp\u003eAdditionally, Jim has argued before the Supreme Court of South Carolina on several high-profile issues. As lead counsel for the Speaker of the House of Representatives, Jim successfully defended the constitutionality of The Heritage Act, which removed the Confederate flag from the dome of the State House. Also, as lead counsel for the Speaker of the House of Representatives, Jim successfully defended the constitutionality of legislation allowing counties and cities to impose service fees. Most recently, as lead counsel for the Speaker of the House of Representatives, Jim argued in defense of School Choice legislation.\u003c/p\u003e\n\u003cp\u003ePrior to private practice, Jim clerked for the Honorable Kaye G. Hearn at the South Carolina of Appeals and South Carolina Supreme Court.\u003c/p\u003e","matters":["\u003cp\u003eServed as co-lead counsel for a \u003cstrong\u003elarge hospital system\u003c/strong\u003e in an arbitration against a large Medicare Advantage company, obtaining a multi-million-dollar award in 2025 for 340B underpayments from 2018-2022.\u003c/p\u003e","\u003cp\u003eCurrently serving as co-lead counsel for several \u003cstrong\u003enon-profit and governmental hospital systems\u003c/strong\u003e on in Medicare Advantage-340B disputes. 340B hospitals across the country were harmed to the tune of billions of dollars as a result of Medicare Advantage plans passing through and refusing to remediate an unlawful Medicare rate they paid to 340B hospitals from 2018-2022.\u003c/p\u003e","\u003cp\u003eServed as co-lead counsel for a \u003cstrong\u003elarge state university hospital system\u003c/strong\u003e in a litigation against a departing physician group, obtaining a high-dollar settlement for misappropriation of hospital proprietary information and trade secrets. This case was important to the hospital in protecting its ability to invest in innovative service lines without fear of competitors \u0026ldquo;jumping the line\u0026rdquo; by poaching the hospital\u0026rsquo;s employees and playbook.\u003c/p\u003e","\u003cp\u003eServed as lead counsel for the \u003cstrong\u003eSpeaker of the South Carolina House of Representatives\u003c/strong\u003e in the \u0026ldquo;Heritage Act case\u0026rdquo; commenced in the original jurisdiction of the South Carolina Supreme Court. After briefing and oral argument in support of the Heritage Act, which removed the Confederate Flag from the State House grounds, the Supreme Court upheld its constitutionality.\u003c/p\u003e","\u003cp\u003eServed as lead counsel for \u003cstrong\u003eCoastal Carolina University\u003c/strong\u003e in a Title IX student discipline case tried in front of a jury before the United States District Court for the District of South Carolina and obtained a defense verdict. This was the first student discipline case tried to a jury in the country.\u003c/p\u003e"],"recognitions":[{"title":"\"Up and Coming,\" Labor \u0026 Employment","detail":"Chambers USA, 2022-2024"},{"title":"Martindale-Hubbell AV Preeminent Peer Review Rating","detail":""},{"title":"Ones to Watch in America, Labor \u0026 Employment","detail":"Best Lawyers, 2021"},{"title":"“Rising Star,” Labor \u0026 Employment","detail":"South Carolina Super Lawyers, 2014-2022"},{"title":"“Legal Elite,” Business Litigation","detail":"Greenville Business Magazine, 2021, 2023"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":13317}]},"capability_group_id":2},"created_at":"2026-01-30T05:02:45.000Z","updated_at":"2026-01-30T05:02:45.000Z","searchable_text":"Gilliam{{ FIELD }}{:title=\u0026gt;\"\\\"Up and Coming,\\\" Labor \u0026amp; Employment\", :detail=\u0026gt;\"Chambers USA, 2022-2024\"}{{ FIELD }}{:title=\u0026gt;\"Martindale-Hubbell AV Preeminent Peer Review Rating\", :detail=\u0026gt;\"\"}{{ FIELD }}{:title=\u0026gt;\"Ones to Watch in America, Labor \u0026amp; Employment\", :detail=\u0026gt;\"Best Lawyers, 2021\"}{{ FIELD }}{:title=\u0026gt;\"“Rising Star,” Labor \u0026amp; Employment\", :detail=\u0026gt;\"South Carolina Super Lawyers, 2014-2022\"}{{ FIELD }}{:title=\u0026gt;\"“Legal Elite,” Business Litigation\", :detail=\u0026gt;\"Greenville Business Magazine, 2021, 2023\"}{{ FIELD }}Served as co-lead counsel for a large hospital system in an arbitration against a large Medicare Advantage company, obtaining a multi-million-dollar award in 2025 for 340B underpayments from 2018-2022.{{ FIELD }}Currently serving as co-lead counsel for several non-profit and governmental hospital systems on in Medicare Advantage-340B disputes. 340B hospitals across the country were harmed to the tune of billions of dollars as a result of Medicare Advantage plans passing through and refusing to remediate an unlawful Medicare rate they paid to 340B hospitals from 2018-2022.{{ FIELD }}Served as co-lead counsel for a large state university hospital system in a litigation against a departing physician group, obtaining a high-dollar settlement for misappropriation of hospital proprietary information and trade secrets. This case was important to the hospital in protecting its ability to invest in innovative service lines without fear of competitors “jumping the line” by poaching the hospital’s employees and playbook.{{ FIELD }}Served as lead counsel for the Speaker of the South Carolina House of Representatives in the “Heritage Act case” commenced in the original jurisdiction of the South Carolina Supreme Court. After briefing and oral argument in support of the Heritage Act, which removed the Confederate Flag from the State House grounds, the Supreme Court upheld its constitutionality.{{ FIELD }}Served as lead counsel for Coastal Carolina University in a Title IX student discipline case tried in front of a jury before the United States District Court for the District of South Carolina and obtained a defense verdict. This was the first student discipline case tried to a jury in the country.{{ FIELD }}Jim Gilliam is a partner in the firm’s Healthcare practice. Jim’s practice is focused on healthcare litigation. Jim’s capabilities include commercial and government managed care, complex business litigation, arbitration, mediation, class/collective actions, investigations, and appellate advocacy. \nJim represents healthcare providers in a variety of business disputes, on issues ranging from government and commercial reimbursement, misappropriation of hospital proprietary information, and post-M\u0026amp;A disputes. Jim also represents healthcare providers in government investigations, including allegations of Medicaid and Medicare billing fraud and federal/state compliance audits. Jim uses his depth and breadth of experience to assist healthcare providers in navigating a heavily regulated and complex business environment.\nJim has significant courtroom experience, having tried numerous cases and argued multiple appeals. In addition to his healthcare practice, Jim has represented governmental entities and educational institutions on marquis litigations over the course of his career. One of Jim’s more noteworthy representations includes successfully representing a large public institution in a five-day federal jury trial involving Title IX of the Education Amendments of 1972. This was the first trial of its kind in the country.\nAdditionally, Jim has argued before the Supreme Court of South Carolina on several high-profile issues. As lead counsel for the Speaker of the House of Representatives, Jim successfully defended the constitutionality of The Heritage Act, which removed the Confederate flag from the dome of the State House. Also, as lead counsel for the Speaker of the House of Representatives, Jim successfully defended the constitutionality of legislation allowing counties and cities to impose service fees. Most recently, as lead counsel for the Speaker of the House of Representatives, Jim argued in defense of School Choice legislation.\nPrior to private practice, Jim clerked for the Honorable Kaye G. Hearn at the South Carolina of Appeals and South Carolina Supreme Court. Partner \"Up and Coming,\" Labor \u0026amp; Employment Chambers USA, 2022-2024 Martindale-Hubbell AV Preeminent Peer Review Rating  Ones to Watch in America, Labor \u0026amp; Employment Best Lawyers, 2021 “Rising Star,” Labor \u0026amp; Employment South Carolina Super Lawyers, 2014-2022 “Legal Elite,” Business Litigation Greenville Business Magazine, 2021, 2023 Newberry College  Charleston School of Law Charleston School of Law U.S. Court of Appeals for the Fourth Circuit U.S. Court of Appeals for the Sixth Circuit U.S. District Court for the District of South Carolina South Carolina Law Clerk, Honorable Kaye G. Hearn, Chief Judge, South Carolina Court of Appeals Law Clerk, Honorable Kaye G. Hearn, Associate Justice, South Carolina Supreme Court Served as co-lead counsel for a large hospital system in an arbitration against a large Medicare Advantage company, obtaining a multi-million-dollar award in 2025 for 340B underpayments from 2018-2022. Currently serving as co-lead counsel for several non-profit and governmental hospital systems on in Medicare Advantage-340B disputes. 340B hospitals across the country were harmed to the tune of billions of dollars as a result of Medicare Advantage plans passing through and refusing to remediate an unlawful Medicare rate they paid to 340B hospitals from 2018-2022. Served as co-lead counsel for a large state university hospital system in a litigation against a departing physician group, obtaining a high-dollar settlement for misappropriation of hospital proprietary information and trade secrets. This case was important to the hospital in protecting its ability to invest in innovative service lines without fear of competitors “jumping the line” by poaching the hospital’s employees and playbook. Served as lead counsel for the Speaker of the South Carolina House of Representatives in the “Heritage Act case” commenced in the original jurisdiction of the South Carolina Supreme Court. After briefing and oral argument in support of the Heritage Act, which removed the Confederate Flag from the State House grounds, the Supreme Court upheld its constitutionality. Served as lead counsel for Coastal Carolina University in a Title IX student discipline case tried in front of a jury before the United States District Court for the District of South Carolina and obtained a defense verdict. This was the first student discipline case tried to a jury in the country.","searchable_name":"James K. Gilliam (Jim)","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":34,"capability_group_featured":null,"home_page_featured":null},{"id":426593,"version":1,"owner_type":"Person","owner_id":5003,"payload":{"bio":"\u003cp\u003eEric Gladbach defends companies in federal and state courts nationwide in complex class and mass action litigation. He has successfully litigated and managed putative class, mass and individual actions alleging false advertising, unfair business practices, unfair and deceptive trade practices, consumer fraud, consumer protection, products liability, and a wide range of common law personal injury and property damage claims.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eEric has represented clients in a wide range of industries, including some of the largest automobile manufacturers and component manufacturers, consumer product manufacturers, integrated energy companies, pharmaceutical and biotechnology manufacturers, medical device manufacturers, financial services, insurance, building supplies, and railroads.\u003c/p\u003e","slug":"eric-gladbach","email":"egladbach@kslaw.com","phone":null,"matters":["\u003cp\u003eSuccessfully represented, pro bono, a Vietnam veteran where the landlord was seeking to remove the tenant and where the landlord subsequently declared bankruptcy.\u003c/p\u003e","\u003cp\u003eSuccessfully made numerous proffers to claimants\u0026rsquo; counsel in filed and unfiled class actions alleging consumer fraud and false advertising.\u003c/p\u003e","\u003cp\u003eAdvised a safety appliance manufacturer and an integrated energy company regarding risk mitigation measures for certain products and processes.\u003c/p\u003e","\u003cp\u003eNegotiated the resolution and executed the implementation of the relief for thousands of cases and claims alleging products liability claims relating to the use of a herbicide for a multinational pharmaceutical and biotechnology company.\u003c/p\u003e","\u003cp\u003eLitigated and resolved for a safety appliance manufacturer a mass action alleging personal injury to emergency services personnel due to their use of certain protective equipment.\u003c/p\u003e","\u003cp\u003eLitigated and resolved for a global consumer products manufacturer five putative class actions pending in three federal and state courts in actions alleging false advertising and marketing.\u003c/p\u003e","\u003cp\u003eOversaw the drafting of relevant documents for, assisted in negotiating, and executed the implementation of the relief for numerous eight- and nine-figure class actions for a global automobile manufacturer. These cases were pending in federal and state MDLs consolidated actions, and individually in the United States.\u003c/p\u003e","\u003cp\u003eResolved hundreds of products liability cases involving an automobile manufacturer using a novel and streamlined Intensive Settlement Process that has been praised by federal and state courts.\u003c/p\u003e","\u003cp\u003eObtained the granting in whole or in part of motions to dismiss on behalf of a global consumer products manufacturer in putative class actions alleging false advertising and consumer fraud.\u003c/p\u003e","\u003cp\u003eObtained the partial granting of motions to dismiss on behalf of an automobile manufacturer in putative class actions alleging consumer fraud.\u003c/p\u003e","\u003cp\u003eLitigated and resolved, on behalf of an international consumer electronics manufacturer, a class action alleging defective mobile phones.\u003c/p\u003e","\u003cp\u003eSuccessfully made numerous proffers to claimants\u0026rsquo; counsel in filed and unfiled class actions alleging consumer fraud and false advertising.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":106,"guid":"106.capabilities","index":0,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":1,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":5,"source":"smartTags"},{"id":17,"guid":"17.capabilities","index":6,"source":"capabilities"},{"id":16,"guid":"16.capabilities","index":7,"source":"capabilities"},{"id":74,"guid":"74.capabilities","index":8,"source":"capabilities"},{"id":762,"guid":"762.smart_tags","index":9,"source":"smartTags"},{"id":970,"guid":"970.smart_tags","index":10,"source":"smartTags"},{"id":112,"guid":"112.capabilities","index":11,"source":"capabilities"},{"id":125,"guid":"125.capabilities","index":12,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":13,"source":"smartTags"}],"is_active":true,"last_name":"Gladbach","nick_name":"Eric","clerkships":[],"first_name":"Eric","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Named General Commercial Attorney of the Year ","detail":"Benchmark Litigation, 2017"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eEric Gladbach defends companies in federal and state courts nationwide in complex class and mass action litigation. He has successfully litigated and managed putative class, mass and individual actions alleging false advertising, unfair business practices, unfair and deceptive trade practices, consumer fraud, consumer protection, products liability, and a wide range of common law personal injury and property damage claims.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eEric has represented clients in a wide range of industries, including some of the largest automobile manufacturers and component manufacturers, consumer product manufacturers, integrated energy companies, pharmaceutical and biotechnology manufacturers, medical device manufacturers, financial services, insurance, building supplies, and railroads.\u003c/p\u003e","matters":["\u003cp\u003eSuccessfully represented, pro bono, a Vietnam veteran where the landlord was seeking to remove the tenant and where the landlord subsequently declared bankruptcy.\u003c/p\u003e","\u003cp\u003eSuccessfully made numerous proffers to claimants\u0026rsquo; counsel in filed and unfiled class actions alleging consumer fraud and false advertising.\u003c/p\u003e","\u003cp\u003eAdvised a safety appliance manufacturer and an integrated energy company regarding risk mitigation measures for certain products and processes.\u003c/p\u003e","\u003cp\u003eNegotiated the resolution and executed the implementation of the relief for thousands of cases and claims alleging products liability claims relating to the use of a herbicide for a multinational pharmaceutical and biotechnology company.\u003c/p\u003e","\u003cp\u003eLitigated and resolved for a safety appliance manufacturer a mass action alleging personal injury to emergency services personnel due to their use of certain protective equipment.\u003c/p\u003e","\u003cp\u003eLitigated and resolved for a global consumer products manufacturer five putative class actions pending in three federal and state courts in actions alleging false advertising and marketing.\u003c/p\u003e","\u003cp\u003eOversaw the drafting of relevant documents for, assisted in negotiating, and executed the implementation of the relief for numerous eight- and nine-figure class actions for a global automobile manufacturer. These cases were pending in federal and state MDLs consolidated actions, and individually in the United States.\u003c/p\u003e","\u003cp\u003eResolved hundreds of products liability cases involving an automobile manufacturer using a novel and streamlined Intensive Settlement Process that has been praised by federal and state courts.\u003c/p\u003e","\u003cp\u003eObtained the granting in whole or in part of motions to dismiss on behalf of a global consumer products manufacturer in putative class actions alleging false advertising and consumer fraud.\u003c/p\u003e","\u003cp\u003eObtained the partial granting of motions to dismiss on behalf of an automobile manufacturer in putative class actions alleging consumer fraud.\u003c/p\u003e","\u003cp\u003eLitigated and resolved, on behalf of an international consumer electronics manufacturer, a class action alleging defective mobile phones.\u003c/p\u003e","\u003cp\u003eSuccessfully made numerous proffers to claimants\u0026rsquo; counsel in filed and unfiled class actions alleging consumer fraud and false advertising.\u003c/p\u003e"],"recognitions":[{"title":"Named General Commercial Attorney of the Year ","detail":"Benchmark Litigation, 2017"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5141}]},"capability_group_id":3},"created_at":"2025-05-26T04:55:04.000Z","updated_at":"2025-05-26T04:55:04.000Z","searchable_text":"Gladbach{{ FIELD }}{:title=\u0026gt;\"Named General Commercial Attorney of the Year \", :detail=\u0026gt;\"Benchmark Litigation, 2017\"}{{ FIELD }}Successfully represented, pro bono, a Vietnam veteran where the landlord was seeking to remove the tenant and where the landlord subsequently declared bankruptcy.{{ FIELD }}Successfully made numerous proffers to claimants’ counsel in filed and unfiled class actions alleging consumer fraud and false advertising.{{ FIELD }}Advised a safety appliance manufacturer and an integrated energy company regarding risk mitigation measures for certain products and processes.{{ FIELD }}Negotiated the resolution and executed the implementation of the relief for thousands of cases and claims alleging products liability claims relating to the use of a herbicide for a multinational pharmaceutical and biotechnology company.{{ FIELD }}Litigated and resolved for a safety appliance manufacturer a mass action alleging personal injury to emergency services personnel due to their use of certain protective equipment.{{ FIELD }}Litigated and resolved for a global consumer products manufacturer five putative class actions pending in three federal and state courts in actions alleging false advertising and marketing.{{ FIELD }}Oversaw the drafting of relevant documents for, assisted in negotiating, and executed the implementation of the relief for numerous eight- and nine-figure class actions for a global automobile manufacturer. These cases were pending in federal and state MDLs consolidated actions, and individually in the United States.{{ FIELD }}Resolved hundreds of products liability cases involving an automobile manufacturer using a novel and streamlined Intensive Settlement Process that has been praised by federal and state courts.{{ FIELD }}Obtained the granting in whole or in part of motions to dismiss on behalf of a global consumer products manufacturer in putative class actions alleging false advertising and consumer fraud.{{ FIELD }}Obtained the partial granting of motions to dismiss on behalf of an automobile manufacturer in putative class actions alleging consumer fraud.{{ FIELD }}Litigated and resolved, on behalf of an international consumer electronics manufacturer, a class action alleging defective mobile phones.{{ FIELD }}Successfully made numerous proffers to claimants’ counsel in filed and unfiled class actions alleging consumer fraud and false advertising.{{ FIELD }}Eric Gladbach defends companies in federal and state courts nationwide in complex class and mass action litigation. He has successfully litigated and managed putative class, mass and individual actions alleging false advertising, unfair business practices, unfair and deceptive trade practices, consumer fraud, consumer protection, products liability, and a wide range of common law personal injury and property damage claims.\nEric has represented clients in a wide range of industries, including some of the largest automobile manufacturers and component manufacturers, consumer product manufacturers, integrated energy companies, pharmaceutical and biotechnology manufacturers, medical device manufacturers, financial services, insurance, building supplies, and railroads. Partner Named General Commercial Attorney of the Year  Benchmark Litigation, 2017 New Jersey New York Successfully represented, pro bono, a Vietnam veteran where the landlord was seeking to remove the tenant and where the landlord subsequently declared bankruptcy. Successfully made numerous proffers to claimants’ counsel in filed and unfiled class actions alleging consumer fraud and false advertising. Advised a safety appliance manufacturer and an integrated energy company regarding risk mitigation measures for certain products and processes. Negotiated the resolution and executed the implementation of the relief for thousands of cases and claims alleging products liability claims relating to the use of a herbicide for a multinational pharmaceutical and biotechnology company. Litigated and resolved for a safety appliance manufacturer a mass action alleging personal injury to emergency services personnel due to their use of certain protective equipment. Litigated and resolved for a global consumer products manufacturer five putative class actions pending in three federal and state courts in actions alleging false advertising and marketing. Oversaw the drafting of relevant documents for, assisted in negotiating, and executed the implementation of the relief for numerous eight- and nine-figure class actions for a global automobile manufacturer. These cases were pending in federal and state MDLs consolidated actions, and individually in the United States. Resolved hundreds of products liability cases involving an automobile manufacturer using a novel and streamlined Intensive Settlement Process that has been praised by federal and state courts. Obtained the granting in whole or in part of motions to dismiss on behalf of a global consumer products manufacturer in putative class actions alleging false advertising and consumer fraud. Obtained the partial granting of motions to dismiss on behalf of an automobile manufacturer in putative class actions alleging consumer fraud. Litigated and resolved, on behalf of an international consumer electronics manufacturer, a class action alleging defective mobile phones. Successfully made numerous proffers to claimants’ counsel in filed and unfiled class actions alleging consumer fraud and false advertising.","searchable_name":"Eric Gladbach","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":427195,"version":1,"owner_type":"Person","owner_id":6479,"payload":{"bio":"\u003cp\u003eJessica Gold has experience in a wide range of complex litigation, including product liability, toxic tort, pharmaceutical and medical device litigation and sales practices litigation. She has experience defending clients in mass tort actions, multi-district litigations and consumer class actions. At both the state and federal court level, Jessica works to develop and implement strategic resolution options for clients facing large-scale class actions, commercial litigation and mass torts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJessica has helped major global corporations design and execute multijurisdictional exit strategies resulting in the resolution of thousands of mass claims.\u0026nbsp; \u0026nbsp;\u003c/p\u003e","slug":"jessica-gold","email":"jgold@kslaw.com","phone":null,"matters":["\u003cp\u003eServe as national resolution counsel to a multinational manufacturer of medical devices in all claims concerning hernia mesh products, with cases filed in federal multidistrict litigation, coordinated state court proceedings and one-off state courts across the country.\u003c/p\u003e","\u003cp\u003eServe as national resolution counsel to a medical device manufacturer of inferior vena cava (IVC) filters, with cases filed nationwide, including successfully designing and implementing a comprehensive resolution strategy that resolved the great majority of the cases pending in the litigation.\u003c/p\u003e","\u003cp\u003eRepresented a multinational medical device manufacturer as national resolution counsel in one of the country\u0026rsquo;s largest MDLs and parallel state court proceedings involving transvaginal mesh devices, including creating and executing a resolution plan and negotiating and administering large scale settlements with the plaintiffs\u0026rsquo; firms representing the bulk of the plaintiffs in the litigation.\u003c/p\u003e","\u003cp\u003eServed as resolution counsel to one of the world\u0026rsquo;s largest manufacturers of medical devices in defense of claims related to implantable intrathecal pumps.\u003c/p\u003e","\u003cp\u003eServed as part of a team that settled a set of cases for a multinational automobile manufacturer alleging breach of warranties regarding transmissions and diesel engines.\u003c/p\u003e","\u003cp\u003eRepresented a multinational pharmaceutical company as national settlement counsel in a mass tort litigation involving a chemotherapy drug product.\u003c/p\u003e","\u003cp\u003eServed as part of a team representing an automobile manufacturer in a billion-dollar settlement of one of the largest class action resolutions in the automobile industry.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":1,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":2,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":5,"source":"capabilities"},{"id":762,"guid":"762.smart_tags","index":6,"source":"smartTags"},{"id":761,"guid":"761.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Gold","nick_name":"Jessica","clerkships":[],"first_name":"Jessica","title_rank":9999,"updated_by":32,"law_schools":[{"id":1403,"meta":{"degree":"J.D.","honors":"Magna Cum Laude","is_law_school":"1","graduation_date":"2008-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eJessica Gold has experience in a wide range of complex litigation, including product liability, toxic tort, pharmaceutical and medical device litigation and sales practices litigation. She has experience defending clients in mass tort actions, multi-district litigations and consumer class actions. At both the state and federal court level, Jessica works to develop and implement strategic resolution options for clients facing large-scale class actions, commercial litigation and mass torts.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eJessica has helped major global corporations design and execute multijurisdictional exit strategies resulting in the resolution of thousands of mass claims.\u0026nbsp; \u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eServe as national resolution counsel to a multinational manufacturer of medical devices in all claims concerning hernia mesh products, with cases filed in federal multidistrict litigation, coordinated state court proceedings and one-off state courts across the country.\u003c/p\u003e","\u003cp\u003eServe as national resolution counsel to a medical device manufacturer of inferior vena cava (IVC) filters, with cases filed nationwide, including successfully designing and implementing a comprehensive resolution strategy that resolved the great majority of the cases pending in the litigation.\u003c/p\u003e","\u003cp\u003eRepresented a multinational medical device manufacturer as national resolution counsel in one of the country\u0026rsquo;s largest MDLs and parallel state court proceedings involving transvaginal mesh devices, including creating and executing a resolution plan and negotiating and administering large scale settlements with the plaintiffs\u0026rsquo; firms representing the bulk of the plaintiffs in the litigation.\u003c/p\u003e","\u003cp\u003eServed as resolution counsel to one of the world\u0026rsquo;s largest manufacturers of medical devices in defense of claims related to implantable intrathecal pumps.\u003c/p\u003e","\u003cp\u003eServed as part of a team that settled a set of cases for a multinational automobile manufacturer alleging breach of warranties regarding transmissions and diesel engines.\u003c/p\u003e","\u003cp\u003eRepresented a multinational pharmaceutical company as national settlement counsel in a mass tort litigation involving a chemotherapy drug product.\u003c/p\u003e","\u003cp\u003eServed as part of a team representing an automobile manufacturer in a billion-dollar settlement of one of the largest class action resolutions in the automobile industry.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10350}]},"capability_group_id":3},"created_at":"2025-05-26T04:59:12.000Z","updated_at":"2025-05-26T04:59:12.000Z","searchable_text":"Gold{{ FIELD }}Serve as national resolution counsel to a multinational manufacturer of medical devices in all claims concerning hernia mesh products, with cases filed in federal multidistrict litigation, coordinated state court proceedings and one-off state courts across the country.{{ FIELD }}Serve as national resolution counsel to a medical device manufacturer of inferior vena cava (IVC) filters, with cases filed nationwide, including successfully designing and implementing a comprehensive resolution strategy that resolved the great majority of the cases pending in the litigation.{{ FIELD }}Represented a multinational medical device manufacturer as national resolution counsel in one of the country’s largest MDLs and parallel state court proceedings involving transvaginal mesh devices, including creating and executing a resolution plan and negotiating and administering large scale settlements with the plaintiffs’ firms representing the bulk of the plaintiffs in the litigation.{{ FIELD }}Served as resolution counsel to one of the world’s largest manufacturers of medical devices in defense of claims related to implantable intrathecal pumps.{{ FIELD }}Served as part of a team that settled a set of cases for a multinational automobile manufacturer alleging breach of warranties regarding transmissions and diesel engines.{{ FIELD }}Represented a multinational pharmaceutical company as national settlement counsel in a mass tort litigation involving a chemotherapy drug product.{{ FIELD }}Served as part of a team representing an automobile manufacturer in a billion-dollar settlement of one of the largest class action resolutions in the automobile industry.{{ FIELD }}Jessica Gold has experience in a wide range of complex litigation, including product liability, toxic tort, pharmaceutical and medical device litigation and sales practices litigation. She has experience defending clients in mass tort actions, multi-district litigations and consumer class actions. At both the state and federal court level, Jessica works to develop and implement strategic resolution options for clients facing large-scale class actions, commercial litigation and mass torts.\nJessica has helped major global corporations design and execute multijurisdictional exit strategies resulting in the resolution of thousands of mass claims.    Partner Binghamton University Binghamton University New York Law School New York Law School New York Serve as national resolution counsel to a multinational manufacturer of medical devices in all claims concerning hernia mesh products, with cases filed in federal multidistrict litigation, coordinated state court proceedings and one-off state courts across the country. Serve as national resolution counsel to a medical device manufacturer of inferior vena cava (IVC) filters, with cases filed nationwide, including successfully designing and implementing a comprehensive resolution strategy that resolved the great majority of the cases pending in the litigation. Represented a multinational medical device manufacturer as national resolution counsel in one of the country’s largest MDLs and parallel state court proceedings involving transvaginal mesh devices, including creating and executing a resolution plan and negotiating and administering large scale settlements with the plaintiffs’ firms representing the bulk of the plaintiffs in the litigation. Served as resolution counsel to one of the world’s largest manufacturers of medical devices in defense of claims related to implantable intrathecal pumps. Served as part of a team that settled a set of cases for a multinational automobile manufacturer alleging breach of warranties regarding transmissions and diesel engines. Represented a multinational pharmaceutical company as national settlement counsel in a mass tort litigation involving a chemotherapy drug product. Served as part of a team representing an automobile manufacturer in a billion-dollar settlement of one of the largest class action resolutions in the automobile industry.","searchable_name":"Jessica Gold","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":32,"capability_group_featured":null,"home_page_featured":null},{"id":427199,"version":1,"owner_type":"Person","owner_id":6437,"payload":{"bio":"\u003cp\u003eOlivier is a partner in King \u0026amp; Spalding\u0026rsquo;s Paris office advising on tax issues related to domestic and cross-border transactions involving mergers, acquisitions and group restructuring operations with a specific focus on the pharmaceutical industry and, more generally, the healthcare, new technologies and finance sectors.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHe also advises company directors and key managers in the tax structuring of their professional and personal assets. His expertise also includes tax litigation and criminal proceedings relating to tax offences.\u003c/p\u003e","slug":"olivier-goldstein","email":"ogoldstein@kslaw.com","phone":null,"matters":["\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003eEurofins Scientific\u003c/strong\u003e\u0026nbsp;on the \u0026euro;230 m acquisition of Biomnis\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":37,"guid":"37.capabilities","index":1,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":2,"source":"capabilities"},{"id":19,"guid":"19.capabilities","index":3,"source":"capabilities"},{"id":11,"guid":"11.capabilities","index":4,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":5,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":6,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":7,"source":"capabilities"}],"is_active":true,"last_name":"Goldstein","nick_name":"Olivier","clerkships":[],"first_name":"Olivier","title_rank":9999,"updated_by":202,"law_schools":[{"id":2976,"meta":{"degree":"Master in Business and Tax Law","honors":"","is_law_school":"1","graduation_date":"1997-01-01 00:00:00"},"order":2,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ranked in Tax","detail":"Best Lawyers, 2022"},{"title":"Ranked excellent in LBO tax","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Taxation of associations and non-profit organizations","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Transaction tax","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Tax litigation","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Taxation of international groups","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked highly recommended in Transfer pricing tax","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked highly recommended in VAT","detail":"Décideurs Leadersleague, 2022"},{"title":"Two-stars-ranked ranked in tax transactional, tax litigation and transfer pricing","detail":"ODA, 2022"}],"linked_in_url":"https://www.linkedin.com/in/olivier-goldstein-9188b36/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eOlivier is a partner in King \u0026amp; Spalding\u0026rsquo;s Paris office advising on tax issues related to domestic and cross-border transactions involving mergers, acquisitions and group restructuring operations with a specific focus on the pharmaceutical industry and, more generally, the healthcare, new technologies and finance sectors.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHe also advises company directors and key managers in the tax structuring of their professional and personal assets. His expertise also includes tax litigation and criminal proceedings relating to tax offences.\u003c/p\u003e","matters":["\u003cp\u003eAdvised\u0026nbsp;\u003cstrong\u003eEurofins Scientific\u003c/strong\u003e\u0026nbsp;on the \u0026euro;230 m acquisition of Biomnis\u003c/p\u003e"],"recognitions":[{"title":"Ranked in Tax","detail":"Best Lawyers, 2022"},{"title":"Ranked excellent in LBO tax","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Taxation of associations and non-profit organizations","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Transaction tax","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Tax litigation","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked excellent in Taxation of international groups","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked highly recommended in Transfer pricing tax","detail":"Décideurs Leadersleague, 2022"},{"title":"Ranked highly recommended in VAT","detail":"Décideurs Leadersleague, 2022"},{"title":"Two-stars-ranked ranked in tax transactional, tax litigation and transfer pricing","detail":"ODA, 2022"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12747}]},"capability_group_id":1},"created_at":"2025-05-26T04:59:14.000Z","updated_at":"2025-05-26T04:59:14.000Z","searchable_text":"Goldstein{{ FIELD }}{:title=\u0026gt;\"Ranked in Tax\", :detail=\u0026gt;\"Best Lawyers, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked excellent in LBO tax\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked excellent in Taxation of associations and non-profit organizations\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked excellent in Transaction tax\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked excellent in Tax litigation\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked excellent in Taxation of international groups\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked highly recommended in Transfer pricing tax\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Ranked highly recommended in VAT\", :detail=\u0026gt;\"Décideurs Leadersleague, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Two-stars-ranked ranked in tax transactional, tax litigation and transfer pricing\", :detail=\u0026gt;\"ODA, 2022\"}{{ FIELD }}Advised Eurofins Scientific on the €230 m acquisition of Biomnis{{ FIELD }}Olivier is a partner in King \u0026amp; Spalding’s Paris office advising on tax issues related to domestic and cross-border transactions involving mergers, acquisitions and group restructuring operations with a specific focus on the pharmaceutical industry and, more generally, the healthcare, new technologies and finance sectors.\nHe also advises company directors and key managers in the tax structuring of their professional and personal assets. His expertise also includes tax litigation and criminal proceedings relating to tax offences. Partner Ranked in Tax Best Lawyers, 2022 Ranked excellent in LBO tax Décideurs Leadersleague, 2022 Ranked excellent in Taxation of associations and non-profit organizations Décideurs Leadersleague, 2022 Ranked excellent in Transaction tax Décideurs Leadersleague, 2022 Ranked excellent in Tax litigation Décideurs Leadersleague, 2022 Ranked excellent in Taxation of international groups Décideurs Leadersleague, 2022 Ranked highly recommended in Transfer pricing tax Décideurs Leadersleague, 2022 Ranked highly recommended in VAT Décideurs Leadersleague, 2022 Two-stars-ranked ranked in tax transactional, tax litigation and transfer pricing ODA, 2022 University Paris II Panthéon-Assas  Ludwig Maximilian University of Munich  University Paris Dauphine University Paris Dauphine Paris Advised Eurofins Scientific on the €230 m acquisition of Biomnis","searchable_name":"Olivier Goldstein","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445743,"version":1,"owner_type":"Person","owner_id":3914,"payload":{"bio":"\u003cp\u003eIgor Gorlach is a partner in the firm's Data Privacy \u0026amp; Security and Healthcare groups.\u0026nbsp; He advises global companies on privacy and security issues, including government investigations, structuring global compliance programs, addressing incidents, and managing disputes.\u0026nbsp; He also advises innovative healthcare companies on models for the delivery of care, reimbursement, government program requirements, and relationships with payors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIgor manages government investigations focused on privacy, security, consumer protection, and healthcare regulatory requirements.\u0026nbsp; He leverages his deep experience with government investigations to advise clients on practical approaches to compliance, the deployment of business initiatives, and navigation of disputes.\u003c/p\u003e\n\u003cp\u003eIgor advises clients on strategies that account for evolving regulatory requirements, including for structuring partnership arrangements, using information in innovative ways, and deploying novel technologies, such as artificial intelligence and other machine learning solutions.\u0026nbsp;\u003c/p\u003e","slug":"igor-gorlach","email":"igorlach@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":3308}]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":4,"source":"capabilities"},{"id":6,"guid":"6.capabilities","index":5,"source":"capabilities"},{"id":1202,"guid":"1202.smart_tags","index":6,"source":"smartTags"}],"is_active":true,"last_name":"Gorlach","nick_name":"Igor","clerkships":[],"first_name":"Igor","title_rank":9999,"updated_by":202,"law_schools":[{"id":824,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2012-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Ones to Watch","detail":"Best Lawyers, 2021, 2022"},{"title":"Emerging Young Lawyers in Healthcare Award","detail":"American Bar Association, 2020"}],"linked_in_url":null,"seodescription":"Igor Gorlach is a partner in our Government Matters \u0026 Regulation Practice Group. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eIgor Gorlach is a partner in the firm's Data Privacy \u0026amp; Security and Healthcare groups.\u0026nbsp; He advises global companies on privacy and security issues, including government investigations, structuring global compliance programs, addressing incidents, and managing disputes.\u0026nbsp; He also advises innovative healthcare companies on models for the delivery of care, reimbursement, government program requirements, and relationships with payors.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eIgor manages government investigations focused on privacy, security, consumer protection, and healthcare regulatory requirements.\u0026nbsp; He leverages his deep experience with government investigations to advise clients on practical approaches to compliance, the deployment of business initiatives, and navigation of disputes.\u003c/p\u003e\n\u003cp\u003eIgor advises clients on strategies that account for evolving regulatory requirements, including for structuring partnership arrangements, using information in innovative ways, and deploying novel technologies, such as artificial intelligence and other machine learning solutions.\u0026nbsp;\u003c/p\u003e","recognitions":[{"title":"Ones to Watch","detail":"Best Lawyers, 2021, 2022"},{"title":"Emerging Young Lawyers in Healthcare Award","detail":"American Bar Association, 2020"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4220}]},"capability_group_id":2},"created_at":"2026-02-11T20:13:09.000Z","updated_at":"2026-02-11T20:13:09.000Z","searchable_text":"Gorlach{{ FIELD }}{:title=\u0026gt;\"Ones to Watch\", :detail=\u0026gt;\"Best Lawyers, 2021, 2022\"}{{ FIELD }}{:title=\u0026gt;\"Emerging Young Lawyers in Healthcare Award\", :detail=\u0026gt;\"American Bar Association, 2020\"}{{ FIELD }}Igor Gorlach is a partner in the firm's Data Privacy \u0026amp; Security and Healthcare groups.  He advises global companies on privacy and security issues, including government investigations, structuring global compliance programs, addressing incidents, and managing disputes.  He also advises innovative healthcare companies on models for the delivery of care, reimbursement, government program requirements, and relationships with payors. \nIgor manages government investigations focused on privacy, security, consumer protection, and healthcare regulatory requirements.  He leverages his deep experience with government investigations to advise clients on practical approaches to compliance, the deployment of business initiatives, and navigation of disputes.\nIgor advises clients on strategies that account for evolving regulatory requirements, including for structuring partnership arrangements, using information in innovative ways, and deploying novel technologies, such as artificial intelligence and other machine learning solutions.  Igor Gorlach lawyer Partner Ones to Watch Best Lawyers, 2021, 2022 Emerging Young Lawyers in Healthcare Award American Bar Association, 2020 Rice University  Harvard University Harvard Law School Harvard University Harvard Law School U.S. Court of Appeals for the First Circuit U.S. Court of Appeals for the D.C. Circuit District of Columbia Massachusetts Texas American Bar Association","searchable_name":"Igor Gorlach","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":442793,"version":1,"owner_type":"Person","owner_id":5489,"payload":{"bio":"\u003cp\u003eKyle Gotchy works with leading hospitals, health systems, medical groups, technology companies, and related businesses in connection with regulatory matters,\u0026nbsp;operational issues, complex contracting,\u0026nbsp;investigations, and enforcement proceedings.\u0026nbsp;He works closely with in-house counsel, leadership, and other business, clinical, and compliance stakeholders on matters related to the state and federal laws governing providers and suppliers, the physician self-referral (Stark) and anti-kickback laws, Medicare reimbursement, and the development of risk-\u0026nbsp; and value-based payment arrangements. Kyle also\u0026nbsp;works with providers, retailers,\u0026nbsp;and technology companies on the development, implementation, and operation\u0026nbsp;of telemedicine services and other innovative digital health solutions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle draws on the operational perspectives he gained while serving as Senior Counsel at\u0026nbsp;Seattle Children\u0026rsquo;s Hospital and strives to help his clients develop practical legal approaches in furtherance of their key business objectives. His approach to client service\u0026nbsp;is further informed by having\u0026nbsp;completed extensive client secondments at one of the nation's largest health systems and later at a multinational technology company during the launch of its market-leading\u0026nbsp;telehealth product.\u0026nbsp;Prior to entering the legal profession, Kyle completed an internship at the EPA focused on children's environmental health and assisted with analytical and basic sciences research in leading academic and biopharmaceutical laboratories.\u0026nbsp;\u003c/p\u003e","slug":"kyle-gotchy","email":"kgotchy@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented health systems, medical groups, clinical laboratories, and individual physicians in various stages of government investigation by the U.S. Department of Justice, state Medicaid Fraud Control Units, and other law enforcement agencies\u003c/p\u003e","\u003cp\u003eCounseled multinational technology company on a range of issues in connection with the development and implementation of a market leading telehealth service, including scope of practice, professional licensure, reimbursement, prescriptive practice, and patient engagement\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems on the establishment and expansion of multistate telemedicine programs\u003c/p\u003e","\u003cp\u003eRepresenting health system in administrative appeal of Medicare overpayment determination based on adverse findings in a HHS OIG hospital audit report, focused primarily on billing requirements for inpatient rehabilitation facility services\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems and other providers in investigating and self-disclosing potential overpayments to CMS under the Self-Referral Disclosure Protocol (SRDP)\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems and providers in responding to investigations by professional licensing boards\u003c/p\u003e","\u003cp\u003eCounseled health system on the development of a co-management arrangement with a behavioral health hospital for an eating disorder treatment program\u003c/p\u003e","\u003cp\u003eAdvised private equity firms on the legal and business risks in connection with complex healthcare industry acquisitions\u003c/p\u003e","\u003cp\u003eAdvised health system on issues raised under the federal anti-kickback statute and physician self-referral law in connection with a high-profile contract dispute with specialty group\u003c/p\u003e","\u003cp\u003eCounseled multiple manufacturers regarding compliance with reporting obligations under the federal Physician Payments Sunshine Act\u003c/p\u003e","\u003cp\u003eCounseled health system on the development of a cardiology co-management arrangement\u003c/p\u003e","\u003cp\u003eRepresented academic medical center and physician in appealing proposed revocation of Medicare billing privileges\u003c/p\u003e","\u003cp\u003eAdvised concierge medical practice on the development of a telemedicine service\u003c/p\u003e","\u003cp\u003eRepresented coalition of clients in the development and submission of comments to CMS and HHS OIG in response to proposed rules amending the federal anti-kickback statute, the civil monetary penalties law, and the physician self-referral (Stark) law\u003c/p\u003e","\u003cp\u003eCounseled health systems and other providers on compliance with CARES Act and Provider Relief Fund requirements\u003c/p\u003e","\u003cp\u003eAdvised multiple health systems on the development of a range of physician alignment models\u003c/p\u003e","\u003cp\u003eCounseled hospitals, medical groups, and clinical laboratories on collateral issues raised by the exclusion of practitioners from federal heath care programs\u003c/p\u003e","\u003cp\u003eCounseled multiple clinically integrated networks and accountable care organizations located across the country on structuring financial relationships consistently with federal and state fraud and abuse laws and related rules governing participation in Medicare value-based payment programs\u003c/p\u003e","\u003cp\u003eCounseled executive leadership and board of skilled nursing facility regarding resident rights and community engagement\u003c/p\u003e","\u003cp\u003eRepresented health system in negotiations with academic medical center regarding staffing arrangement in support of air transport service\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":3,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":4,"source":"smartTags"},{"id":133,"guid":"133.capabilities","index":5,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":6,"source":"smartTags"},{"id":740,"guid":"740.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Gotchy","nick_name":"Kyle","clerkships":[],"first_name":"Kyle","title_rank":9999,"updated_by":196,"law_schools":[{"id":2412,"meta":{"degree":"J.D.","honors":null,"is_law_school":1,"graduation_date":"2010-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":[{"title":"40 Under 40","detail":"Sacramento Business Journal, 2021"},{"title":"Rising Star","detail":"Washington Super Lawyers, 2019"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKyle Gotchy works with leading hospitals, health systems, medical groups, technology companies, and related businesses in connection with regulatory matters,\u0026nbsp;operational issues, complex contracting,\u0026nbsp;investigations, and enforcement proceedings.\u0026nbsp;He works closely with in-house counsel, leadership, and other business, clinical, and compliance stakeholders on matters related to the state and federal laws governing providers and suppliers, the physician self-referral (Stark) and anti-kickback laws, Medicare reimbursement, and the development of risk-\u0026nbsp; and value-based payment arrangements. Kyle also\u0026nbsp;works with providers, retailers,\u0026nbsp;and technology companies on the development, implementation, and operation\u0026nbsp;of telemedicine services and other innovative digital health solutions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eKyle draws on the operational perspectives he gained while serving as Senior Counsel at\u0026nbsp;Seattle Children\u0026rsquo;s Hospital and strives to help his clients develop practical legal approaches in furtherance of their key business objectives. His approach to client service\u0026nbsp;is further informed by having\u0026nbsp;completed extensive client secondments at one of the nation's largest health systems and later at a multinational technology company during the launch of its market-leading\u0026nbsp;telehealth product.\u0026nbsp;Prior to entering the legal profession, Kyle completed an internship at the EPA focused on children's environmental health and assisted with analytical and basic sciences research in leading academic and biopharmaceutical laboratories.\u0026nbsp;\u003c/p\u003e","matters":["\u003cp\u003eRepresented health systems, medical groups, clinical laboratories, and individual physicians in various stages of government investigation by the U.S. Department of Justice, state Medicaid Fraud Control Units, and other law enforcement agencies\u003c/p\u003e","\u003cp\u003eCounseled multinational technology company on a range of issues in connection with the development and implementation of a market leading telehealth service, including scope of practice, professional licensure, reimbursement, prescriptive practice, and patient engagement\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems on the establishment and expansion of multistate telemedicine programs\u003c/p\u003e","\u003cp\u003eRepresenting health system in administrative appeal of Medicare overpayment determination based on adverse findings in a HHS OIG hospital audit report, focused primarily on billing requirements for inpatient rehabilitation facility services\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems and other providers in investigating and self-disclosing potential overpayments to CMS under the Self-Referral Disclosure Protocol (SRDP)\u003c/p\u003e","\u003cp\u003eRepresented multiple health systems and providers in responding to investigations by professional licensing boards\u003c/p\u003e","\u003cp\u003eCounseled health system on the development of a co-management arrangement with a behavioral health hospital for an eating disorder treatment program\u003c/p\u003e","\u003cp\u003eAdvised private equity firms on the legal and business risks in connection with complex healthcare industry acquisitions\u003c/p\u003e","\u003cp\u003eAdvised health system on issues raised under the federal anti-kickback statute and physician self-referral law in connection with a high-profile contract dispute with specialty group\u003c/p\u003e","\u003cp\u003eCounseled multiple manufacturers regarding compliance with reporting obligations under the federal Physician Payments Sunshine Act\u003c/p\u003e","\u003cp\u003eCounseled health system on the development of a cardiology co-management arrangement\u003c/p\u003e","\u003cp\u003eRepresented academic medical center and physician in appealing proposed revocation of Medicare billing privileges\u003c/p\u003e","\u003cp\u003eAdvised concierge medical practice on the development of a telemedicine service\u003c/p\u003e","\u003cp\u003eRepresented coalition of clients in the development and submission of comments to CMS and HHS OIG in response to proposed rules amending the federal anti-kickback statute, the civil monetary penalties law, and the physician self-referral (Stark) law\u003c/p\u003e","\u003cp\u003eCounseled health systems and other providers on compliance with CARES Act and Provider Relief Fund requirements\u003c/p\u003e","\u003cp\u003eAdvised multiple health systems on the development of a range of physician alignment models\u003c/p\u003e","\u003cp\u003eCounseled hospitals, medical groups, and clinical laboratories on collateral issues raised by the exclusion of practitioners from federal heath care programs\u003c/p\u003e","\u003cp\u003eCounseled multiple clinically integrated networks and accountable care organizations located across the country on structuring financial relationships consistently with federal and state fraud and abuse laws and related rules governing participation in Medicare value-based payment programs\u003c/p\u003e","\u003cp\u003eCounseled executive leadership and board of skilled nursing facility regarding resident rights and community engagement\u003c/p\u003e","\u003cp\u003eRepresented health system in negotiations with academic medical center regarding staffing arrangement in support of air transport service\u003c/p\u003e"],"recognitions":[{"title":"40 Under 40","detail":"Sacramento Business Journal, 2021"},{"title":"Rising Star","detail":"Washington Super Lawyers, 2019"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":7034}]},"capability_group_id":2},"created_at":"2025-11-13T04:57:24.000Z","updated_at":"2025-11-13T04:57:24.000Z","searchable_text":"Gotchy{{ FIELD }}{:title=\u0026gt;\"40 Under 40\", :detail=\u0026gt;\"Sacramento Business Journal, 2021\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star\", :detail=\u0026gt;\"Washington Super Lawyers, 2019\"}{{ FIELD }}Represented health systems, medical groups, clinical laboratories, and individual physicians in various stages of government investigation by the U.S. Department of Justice, state Medicaid Fraud Control Units, and other law enforcement agencies{{ FIELD }}Counseled multinational technology company on a range of issues in connection with the development and implementation of a market leading telehealth service, including scope of practice, professional licensure, reimbursement, prescriptive practice, and patient engagement{{ FIELD }}Represented multiple health systems on the establishment and expansion of multistate telemedicine programs{{ FIELD }}Representing health system in administrative appeal of Medicare overpayment determination based on adverse findings in a HHS OIG hospital audit report, focused primarily on billing requirements for inpatient rehabilitation facility services{{ FIELD }}Represented multiple health systems and other providers in investigating and self-disclosing potential overpayments to CMS under the Self-Referral Disclosure Protocol (SRDP){{ FIELD }}Represented multiple health systems and providers in responding to investigations by professional licensing boards{{ FIELD }}Counseled health system on the development of a co-management arrangement with a behavioral health hospital for an eating disorder treatment program{{ FIELD }}Advised private equity firms on the legal and business risks in connection with complex healthcare industry acquisitions{{ FIELD }}Advised health system on issues raised under the federal anti-kickback statute and physician self-referral law in connection with a high-profile contract dispute with specialty group{{ FIELD }}Counseled multiple manufacturers regarding compliance with reporting obligations under the federal Physician Payments Sunshine Act{{ FIELD }}Counseled health system on the development of a cardiology co-management arrangement{{ FIELD }}Represented academic medical center and physician in appealing proposed revocation of Medicare billing privileges{{ FIELD }}Advised concierge medical practice on the development of a telemedicine service{{ FIELD }}Represented coalition of clients in the development and submission of comments to CMS and HHS OIG in response to proposed rules amending the federal anti-kickback statute, the civil monetary penalties law, and the physician self-referral (Stark) law{{ FIELD }}Counseled health systems and other providers on compliance with CARES Act and Provider Relief Fund requirements{{ FIELD }}Advised multiple health systems on the development of a range of physician alignment models{{ FIELD }}Counseled hospitals, medical groups, and clinical laboratories on collateral issues raised by the exclusion of practitioners from federal heath care programs{{ FIELD }}Counseled multiple clinically integrated networks and accountable care organizations located across the country on structuring financial relationships consistently with federal and state fraud and abuse laws and related rules governing participation in Medicare value-based payment programs{{ FIELD }}Counseled executive leadership and board of skilled nursing facility regarding resident rights and community engagement{{ FIELD }}Represented health system in negotiations with academic medical center regarding staffing arrangement in support of air transport service{{ FIELD }}Kyle Gotchy works with leading hospitals, health systems, medical groups, technology companies, and related businesses in connection with regulatory matters, operational issues, complex contracting, investigations, and enforcement proceedings. He works closely with in-house counsel, leadership, and other business, clinical, and compliance stakeholders on matters related to the state and federal laws governing providers and suppliers, the physician self-referral (Stark) and anti-kickback laws, Medicare reimbursement, and the development of risk-  and value-based payment arrangements. Kyle also works with providers, retailers, and technology companies on the development, implementation, and operation of telemedicine services and other innovative digital health solutions. \nKyle draws on the operational perspectives he gained while serving as Senior Counsel at Seattle Children’s Hospital and strives to help his clients develop practical legal approaches in furtherance of their key business objectives. His approach to client service is further informed by having completed extensive client secondments at one of the nation's largest health systems and later at a multinational technology company during the launch of its market-leading telehealth product. Prior to entering the legal profession, Kyle completed an internship at the EPA focused on children's environmental health and assisted with analytical and basic sciences research in leading academic and biopharmaceutical laboratories.  Partner 40 Under 40 Sacramento Business Journal, 2021 Rising Star Washington Super Lawyers, 2019 Whitman College  University of Washington-Seattle Campus University of Washington School of Law California Washington American Health Law Association California Society for Healthcare Attorneys Washington State Society of Healthcare Attorneys Represented health systems, medical groups, clinical laboratories, and individual physicians in various stages of government investigation by the U.S. Department of Justice, state Medicaid Fraud Control Units, and other law enforcement agencies Counseled multinational technology company on a range of issues in connection with the development and implementation of a market leading telehealth service, including scope of practice, professional licensure, reimbursement, prescriptive practice, and patient engagement Represented multiple health systems on the establishment and expansion of multistate telemedicine programs Representing health system in administrative appeal of Medicare overpayment determination based on adverse findings in a HHS OIG hospital audit report, focused primarily on billing requirements for inpatient rehabilitation facility services Represented multiple health systems and other providers in investigating and self-disclosing potential overpayments to CMS under the Self-Referral Disclosure Protocol (SRDP) Represented multiple health systems and providers in responding to investigations by professional licensing boards Counseled health system on the development of a co-management arrangement with a behavioral health hospital for an eating disorder treatment program Advised private equity firms on the legal and business risks in connection with complex healthcare industry acquisitions Advised health system on issues raised under the federal anti-kickback statute and physician self-referral law in connection with a high-profile contract dispute with specialty group Counseled multiple manufacturers regarding compliance with reporting obligations under the federal Physician Payments Sunshine Act Counseled health system on the development of a cardiology co-management arrangement Represented academic medical center and physician in appealing proposed revocation of Medicare billing privileges Advised concierge medical practice on the development of a telemedicine service Represented coalition of clients in the development and submission of comments to CMS and HHS OIG in response to proposed rules amending the federal anti-kickback statute, the civil monetary penalties law, and the physician self-referral (Stark) law Counseled health systems and other providers on compliance with CARES Act and Provider Relief Fund requirements Advised multiple health systems on the development of a range of physician alignment models Counseled hospitals, medical groups, and clinical laboratories on collateral issues raised by the exclusion of practitioners from federal heath care programs Counseled multiple clinically integrated networks and accountable care organizations located across the country on structuring financial relationships consistently with federal and state fraud and abuse laws and related rules governing participation in Medicare value-based payment programs Counseled executive leadership and board of skilled nursing facility regarding resident rights and community engagement Represented health system in negotiations with academic medical center regarding staffing arrangement in support of air transport service","searchable_name":"Kyle Gotchy","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":196,"capability_group_featured":null,"home_page_featured":null},{"id":443287,"version":1,"owner_type":"Person","owner_id":3522,"payload":{"bio":"\u003cp\u003eUlf Grundmann is a partner of the Government Matters Practice Group, and focuses on regulations and compliance regarding the pharmaceutical, medical devices, cosmetic and food industries, and on litigation in the European Union. For more than 28 years, Ulf has advised clients through all stages of the product life cycle, including product development, trademark clearance, labeling, advertising and promotion, product launch, distribution, licensing and compliance in the EU. He also handles all kinds of litigation related to the products, the distribution, intellectual property rights, competition and advertising. This includes aspects related to parallel imports, protection against falsified products, recalls, and product end-of-life. He litigates matters before German and European courts, including the General Court and the Court of Justice of the EU.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eUlf counsels clients in the European Union on regulatory, unfair competition and compliance laws, and represents clients before national and European authorities, including the European Commission. He also works with life science companies on corporate and financial transactions.\u003c/p\u003e\n\u003cp\u003eAs frequent author, speaker and moderator at life sciences and food conferences, Ulf also serves as a lecturer at the Frankfurt School of Finance and Management as well as the DeutscheAnwaltsAkademie.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eLMG Life Sciences EMEA\u003c/em\u003e\u0026nbsp;2023 named Ulf a\u0026nbsp;\"Parallel Import Lawyer of the Year\" for the second following year.\u0026nbsp;\u003cem\u003eJUVE\u003c/em\u003e\u0026nbsp;2023/24\u0026nbsp;named\u0026nbsp;him a \"Leading Name\" for pharmaceutical and medical devices law for the third\u0026nbsp;year in a row. \u003cem\u003eLegal 500 Deutschland\u003c/em\u003e recommends him as leading lawyer in the categories Healthcare and Life Sciences, Consumer Goods and Food Law and Intellectual Property: Unfair Competition. He has been recognized among Germany's leading lawyers for pharmaceuticals, medical devices and food law by legal directories such as\u0026nbsp;\u003cem\u003eJUVE\u003c/em\u003e,\u0026nbsp;\u003cem\u003eLegal 500, Handelsblatt \u003c/em\u003eand\u003cem\u003e best lawyers\u0026nbsp;\u003c/em\u003eand\u003cem\u003e\u0026nbsp;Who's Who Legal\u0026nbsp;\u003c/em\u003efor many years.\u003c/p\u003e\n\u003cp\u003eUlf is counseling clients from the Frankfurt office and temporarily from the Brussels office.\u003c/p\u003e","slug":"ulf-grundmann","email":"ugrundmann@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":81}]},"expertise":[{"id":21,"guid":"21.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":105,"guid":"105.capabilities","index":2,"source":"capabilities"},{"id":13,"guid":"13.capabilities","index":3,"source":"capabilities"},{"id":1,"guid":"1.capabilities","index":4,"source":"capabilities"},{"id":2,"guid":"2.capabilities","index":5,"source":"capabilities"},{"id":106,"guid":"106.capabilities","index":6,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":7,"source":"capabilities"},{"id":104,"guid":"104.capabilities","index":8,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":9,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":10,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":11,"source":"capabilities"},{"id":1303,"guid":"1303.smart_tags","index":12,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":13,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":14,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":15,"source":"capabilities"}],"is_active":true,"last_name":"Grundmann","nick_name":"Ulf","clerkships":[],"first_name":"Ulf","title_rank":9999,"updated_by":35,"law_schools":[],"middle_name":"H.","name_suffix":"","recognitions":[{"title":"Life Sciences Law Firm of the Year Germany","detail":"LMG Life Sciences EMEA, 2023 \u0026 2025"},{"title":"Law Firm Parallel Trade EMEA","detail":"LMG Life Sciences EMEA, 2023"},{"title":"Recommended Lawyer for Life Sciences and Healthcare \u0026 Life Sciences","detail":"Lexology Index (formerly Who's Who Legal) 2025"},{"title":"\"Quick and creative solutions, very good industry knowledge, skillful tactician, especially in court hearings\" ","detail":"Legal 500 Deutschland 2025, Quoting clients"},{"title":"Parallel Import Lawyer of the Year","detail":"LMG Life Sciences EMEA Awards 2022,2023 and 2024"},{"title":"Winner of the Life Sciences category in Germany, an award based on client nominations ","detail":"Client Choice Awards, 2022"},{"title":"\"Leading Name\" for Pharma- and Medical Devices Law","detail":"JUVE, 2020/21-2023/24"},{"title":"Recommended Lawyer for Healthcare and Life Sciences, Consumer Products and Food Law, IP: Unfair Competition","detail":"Legal 500 Deutschland, 2023"},{"title":"\"Ulf Grundmann has a lot of experience and excellent expertise regarding patent and trademark law in the life sciences.\"","detail":"Legal 500 Deutschland 2023, Quoting clients"},{"title":"\"Solves complex issues with a lot of creativity and offers alternative perspectives that [...] lead to better results.\"","detail":"Legal 500 Deutschland 2023, Quoting clients"},{"title":"Recognized one of Germany's Best Intellectual Property Dispute Resolution, Pharmaceuticals and Biotechnology Lawyers","detail":"Handelsblatt and Best Lawyers, 2024-2025"},{"title":"“first choice\"; \"very satisfied\", \"excellent trial lawyer\"","detail":" JUVE, 2021/22, Quoting clients"},{"title":"Recommended Lawyer for Pharmaceuticals and Medical Products and Food Law","detail":"JUVE, 2014/15 - 2023/24"},{"title":"Recognized as National Leader for Life Sciences - Regulatory","detail":"Who's Who Legal, 2021"},{"title":"\"Reliable and excellent in terms of content\" ","detail":"JUVE, 2020/21, Quoting clients"},{"title":"\"Very knowledgeable in life sciences and up to date on any developments on the market.\" ","detail":"Legal 500 Deutschland 2021, Quoting Clients"},{"title":"\"Fast + creative solutions, very good industry knowledge, skilled tactician especially in court proceedings.” ","detail":"Legal 500 Deutschland 2025, Quoting Clients"},{"title":"\"Direct, agile, assertive and client-oriented.” ","detail":"Legal 500 Deutschland 2021, Quoting clients"},{"title":"\"Highly experienced in pharmaceutical, competition, food, trademark and European law” ","detail":"Legal 500 Deutschland 2020, Quoting clients"},{"title":"\"Stands out for his market-leading expertise in compliance to EU regulations in the life sciences sector\" ","detail":"Who's Who Legal Germany, 2020"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"de":{"bio":"\u003cp\u003eUlf Grundmann ist Partner im Frankfurter B\u0026uuml;ro von King \u0026amp; Spalding und Mitglied der Life Sciences-Praxisgruppe. Als Kopf der in 2014 gegr\u0026uuml;ndeten deutschen Life Sciences-Praxis ber\u0026auml;t Ulf Grundmann Hersteller der Medizinprodukte-, Pharma-, Kosmetik- und Lebensmittelbranche und vertritt sie in Rechtsstreitigkeiten seit \u0026uuml;ber 28 Jahren in verschiedenen Phasen des Produktlebenszyklus einschlie\u0026szlig;lich Produktentwicklung, Etikettierung, Werbung und Promotion, Produktmarkteinf\u0026uuml;hrung, Vertrieb, Compliance, hinsichtlich Aspekte im Zusammenhang mit Parallelimporten, Schutz vor gef\u0026auml;lschter Ware, R\u0026uuml;ckrufaktionen sowie End-of-Life-Phase. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eHerr Grundmann ber\u0026auml;t Mandanten in allen Bereichen von EU-rechtlichen Angelegenheiten, unlauterem Wettbewerb und Compliance und vertritt Unternehmen vor nationalen und europ\u0026auml;ischen Beh\u0026ouml;rden, einschlie\u0026szlig;lich der Europ\u0026auml;ischen Kommission. Ulf Grundmann ist seit vielen Jahren als Prozessanwalt, speziell in Berufungsverfahren, t\u0026auml;tig und vertritt Mandanten vor deutschen und europ\u0026auml;ischen Gerichten, einschlie\u0026szlig;lich dem Gericht der Europ\u0026auml;ischen Union und dem Europ\u0026auml;ischen Gerichtshof.\u003c/p\u003e\n\u003cp\u003eUlf Grundmann tritt regelm\u0026auml;\u0026szlig;ig bei verschiedenen Life Sciences und Lebensmittel-Konferenzen als Sprecher und Moderator auf. Au\u0026szlig;erdem ist er als Mitglied des \u0026bdquo;Corporate Advisory Board\u0026ldquo; und Dozent f\u0026uuml;r die Frankfurt School of Finance and Management und f\u0026uuml;r die Deutsche Anwalts Akademie t\u0026auml;tig. Er arbeitet dar\u0026uuml;ber hinaus als Herausgeber der Fachzeitschrift \u003cem\u003eLebensmittel \u0026amp; Recht\u003c/em\u003e, als Autor f\u0026uuml;r das \u003cem\u003eM\u0026uuml;nchener Anwaltshandbuch Gewerblicher Rechtsschutz\u003c/em\u003e und als Herausgeber und Autor f\u0026uuml;r die Publikation \u003cem\u003eGesundheitsbezogene Lebensmittel\u003c/em\u003e.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eLMG Life Sciences EMEA\u003c/em\u003e 2023 hat Ulf Grundmann das zweite Jahr in Folge zum \"Parallel Import Lawyer of the Year\" ausgezeichnet. J\u003cem\u003eUVE \u003c/em\u003e2023/24 f\u0026uuml;hrt\u0026nbsp;ihn das dritte Jahr in Folge als \"F\u0026uuml;hrenden Namen\" im Pharma- und Medizinprodukterecht\u003cstrong\u003e. \u003c/strong\u003e\u003cem\u003eLegal 500 Deutschland\u003c/em\u003e\u0026nbsp;empfiehlt Ulf Grundmann unter den f\u0026uuml;hrenden Namen f\u0026uuml;r Branchenfokus: Gesundheit, Konsumg\u0026uuml;ter und Lebensmittelrecht sowie Gewerblicher Rechtsschutz: Wettbewerbsrecht. Er wird seit vielen Jahren als Experte in Publikationen wie \u003cem\u003eJUVE\u003c/em\u003e, \u003cem\u003eLegal 500, Handelsblatt\u003c/em\u003e\u0026nbsp;und best\u003cem\u003e lawyers\u0026nbsp;\u003c/em\u003eund\u003cem\u003e Whos\u0026rsquo;s Who Legal \u003c/em\u003eempfohlen f\u0026uuml;r die Bereiche Pharma, Medizinprodukte und Lebensmittelrecht.\u003c/p\u003e","recognitions":[{"title":"Gewinner der Kategorie \"Life Sciences\" in Deutschland; der Award beruht auf Nominierungen von Mandanten","detail":"Client Choice Awards, 2022"},{"title":"\"Parallel Import Lawyer of the Year\"","detail":"LMG Life Sciences EMEA Awards 2022 und 2023"},{"title":"\"Führender Berater\" im Bereich Pharma- und Medizinprodukterecht ","detail":"JUVE, 2020/21-2023/25"},{"title":"Empfohlen als Anwalt für die Bereiche Pharma- und Medizinprodukterecht sowie Lebensmittelrecht","detail":"JUVE, 2014/15-2023/25"},{"title":"Empfohlen als Anwalt für die Bereiche Branchenfokus: Gesundheit, Konsumgüter und Lebensmittelrecht sowie Gewerblicher Rechtsschutz: Wettbewerbsrecht","detail":"Legal 500 Deutschland, 2023"},{"title":"\"Ulf Grundmann hat viel Erfahrung und ausgezeichnete Expertise bezüglich Patent- und Markenrecht in den Life Sciences.\"","detail":"Legal 500 Deutschland, 2023 - Mandant"},{"title":"Er löst komplexe Sachverhalte mit viel Kreativität und bietet alternative Sichtweisen, die regelmäßig zu besseren Ergebnissen führen.’","detail":"Legal 500 Deutschland, 2023 - Mandant"},{"title":"Empfohlen unter den besten Anwälten Deutschlands für Gewerblicher Rechtsschutz und Pharmarecht","detail":"Handelsblatt und best lawyers, 2023"},{"title":"„erste Wahl“; „sehr zufrieden“; „exzellenter Prozessanwalt“","detail":"JUVE 2021/22 - Mandanten"},{"title":"\"führt sein Team effizient und bietet kreative Lösungsansätze. Sehr gute Kenntnisse in den Life Sciences und auf dem neuesten Stand über jegliche Neuerungen. Direkt, agil, durchsetzungsstark und mandantenorientiert.\"","detail":"Legal 500 Deutschland, 2021 - Mandant"},{"title":"„zuverlässig u. inhaltl. ausgezeichnet“,","detail":"JUVE 2020/21 - Mandant"},{"title":"\"Sehr erfahren im Pharma-, Wettbewerbs-, Lebensmittel-, Marken- und Europarecht\"","detail":"Legal 500 Deutschland, 2020"},{"title":"\"Stands out for his market-leading expertise in compliance to EU regulations in the life sciences sector\"","detail":"Who is Who Legal, 2020"},{"title":"Empfohlen für Healthcare \u0026 Life Sciences - Regulatory","detail":"Lexology Index (ehem. Who's Who Legal) 2025"}]},"en":{"bio":"\u003cp\u003eUlf Grundmann is a partner of the Government Matters Practice Group, and focuses on regulations and compliance regarding the pharmaceutical, medical devices, cosmetic and food industries, and on litigation in the European Union. For more than 28 years, Ulf has advised clients through all stages of the product life cycle, including product development, trademark clearance, labeling, advertising and promotion, product launch, distribution, licensing and compliance in the EU. He also handles all kinds of litigation related to the products, the distribution, intellectual property rights, competition and advertising. This includes aspects related to parallel imports, protection against falsified products, recalls, and product end-of-life. He litigates matters before German and European courts, including the General Court and the Court of Justice of the EU.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eUlf counsels clients in the European Union on regulatory, unfair competition and compliance laws, and represents clients before national and European authorities, including the European Commission. He also works with life science companies on corporate and financial transactions.\u003c/p\u003e\n\u003cp\u003eAs frequent author, speaker and moderator at life sciences and food conferences, Ulf also serves as a lecturer at the Frankfurt School of Finance and Management as well as the DeutscheAnwaltsAkademie.\u003c/p\u003e\n\u003cp\u003e\u003cem\u003eLMG Life Sciences EMEA\u003c/em\u003e\u0026nbsp;2023 named Ulf a\u0026nbsp;\"Parallel Import Lawyer of the Year\" for the second following year.\u0026nbsp;\u003cem\u003eJUVE\u003c/em\u003e\u0026nbsp;2023/24\u0026nbsp;named\u0026nbsp;him a \"Leading Name\" for pharmaceutical and medical devices law for the third\u0026nbsp;year in a row. \u003cem\u003eLegal 500 Deutschland\u003c/em\u003e recommends him as leading lawyer in the categories Healthcare and Life Sciences, Consumer Goods and Food Law and Intellectual Property: Unfair Competition. He has been recognized among Germany's leading lawyers for pharmaceuticals, medical devices and food law by legal directories such as\u0026nbsp;\u003cem\u003eJUVE\u003c/em\u003e,\u0026nbsp;\u003cem\u003eLegal 500, Handelsblatt \u003c/em\u003eand\u003cem\u003e best lawyers\u0026nbsp;\u003c/em\u003eand\u003cem\u003e\u0026nbsp;Who's Who Legal\u0026nbsp;\u003c/em\u003efor many years.\u003c/p\u003e\n\u003cp\u003eUlf is counseling clients from the Frankfurt office and temporarily from the Brussels office.\u003c/p\u003e","recognitions":[{"title":"Life Sciences Law Firm of the Year Germany","detail":"LMG Life Sciences EMEA, 2023 \u0026 2025"},{"title":"Law Firm Parallel Trade EMEA","detail":"LMG Life Sciences EMEA, 2023"},{"title":"Recommended Lawyer for Life Sciences and Healthcare \u0026 Life Sciences","detail":"Lexology Index (formerly Who's Who Legal) 2025"},{"title":"\"Quick and creative solutions, very good industry knowledge, skillful tactician, especially in court hearings\" ","detail":"Legal 500 Deutschland 2025, Quoting clients"},{"title":"Parallel Import Lawyer of the Year","detail":"LMG Life Sciences EMEA Awards 2022,2023 and 2024"},{"title":"Winner of the Life Sciences category in Germany, an award based on client nominations ","detail":"Client Choice Awards, 2022"},{"title":"\"Leading Name\" for Pharma- and Medical Devices Law","detail":"JUVE, 2020/21-2023/24"},{"title":"Recommended Lawyer for Healthcare and Life Sciences, Consumer Products and Food Law, IP: Unfair Competition","detail":"Legal 500 Deutschland, 2023"},{"title":"\"Ulf Grundmann has a lot of experience and excellent expertise regarding patent and trademark law in the life sciences.\"","detail":"Legal 500 Deutschland 2023, Quoting clients"},{"title":"\"Solves complex issues with a lot of creativity and offers alternative perspectives that [...] lead to better results.\"","detail":"Legal 500 Deutschland 2023, Quoting clients"},{"title":"Recognized one of Germany's Best Intellectual Property Dispute Resolution, Pharmaceuticals and Biotechnology Lawyers","detail":"Handelsblatt and Best Lawyers, 2024-2025"},{"title":"“first choice\"; \"very satisfied\", \"excellent trial lawyer\"","detail":" JUVE, 2021/22, Quoting clients"},{"title":"Recommended Lawyer for Pharmaceuticals and Medical Products and Food Law","detail":"JUVE, 2014/15 - 2023/24"},{"title":"Recognized as National Leader for Life Sciences - Regulatory","detail":"Who's Who Legal, 2021"},{"title":"\"Reliable and excellent in terms of content\" ","detail":"JUVE, 2020/21, Quoting clients"},{"title":"\"Very knowledgeable in life sciences and up to date on any developments on the market.\" ","detail":"Legal 500 Deutschland 2021, Quoting Clients"},{"title":"\"Fast + creative solutions, very good industry knowledge, skilled tactician especially in court proceedings.” ","detail":"Legal 500 Deutschland 2025, Quoting Clients"},{"title":"\"Direct, agile, assertive and client-oriented.” ","detail":"Legal 500 Deutschland 2021, Quoting clients"},{"title":"\"Highly experienced in pharmaceutical, competition, food, trademark and European law” ","detail":"Legal 500 Deutschland 2020, Quoting clients"},{"title":"\"Stands out for his market-leading expertise in compliance to EU regulations in the life sciences sector\" ","detail":"Who's Who Legal Germany, 2020"}]},"locales":["en","de"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":888}]},"capability_group_id":2},"created_at":"2025-11-26T21:37:35.000Z","updated_at":"2025-11-26T21:37:35.000Z","searchable_text":"Grundmann{{ FIELD }}{:title=\u0026gt;\"Life Sciences Law Firm of the Year Germany\", :detail=\u0026gt;\"LMG Life Sciences EMEA, 2023 \u0026amp; 2025\"}{{ FIELD }}{:title=\u0026gt;\"Law Firm Parallel Trade EMEA\", :detail=\u0026gt;\"LMG Life Sciences EMEA, 2023\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer for Life Sciences and Healthcare \u0026amp; Life Sciences\", :detail=\u0026gt;\"Lexology Index (formerly Who's Who Legal) 2025\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Quick and creative solutions, very good industry knowledge, skillful tactician, especially in court hearings\\\" \", :detail=\u0026gt;\"Legal 500 Deutschland 2025, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"Parallel Import Lawyer of the Year\", :detail=\u0026gt;\"LMG Life Sciences EMEA Awards 2022,2023 and 2024\"}{{ FIELD }}{:title=\u0026gt;\"Winner of the Life Sciences category in Germany, an award based on client nominations \", :detail=\u0026gt;\"Client Choice Awards, 2022\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Leading Name\\\" for Pharma- and Medical Devices Law\", :detail=\u0026gt;\"JUVE, 2020/21-2023/24\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer for Healthcare and Life Sciences, Consumer Products and Food Law, IP: Unfair Competition\", :detail=\u0026gt;\"Legal 500 Deutschland, 2023\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Ulf Grundmann has a lot of experience and excellent expertise regarding patent and trademark law in the life sciences.\\\"\", :detail=\u0026gt;\"Legal 500 Deutschland 2023, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Solves complex issues with a lot of creativity and offers alternative perspectives that [...] lead to better results.\\\"\", :detail=\u0026gt;\"Legal 500 Deutschland 2023, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"Recognized one of Germany's Best Intellectual Property Dispute Resolution, Pharmaceuticals and Biotechnology Lawyers\", :detail=\u0026gt;\"Handelsblatt and Best Lawyers, 2024-2025\"}{{ FIELD }}{:title=\u0026gt;\"“first choice\\\"; \\\"very satisfied\\\", \\\"excellent trial lawyer\\\"\", :detail=\u0026gt;\" JUVE, 2021/22, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"Recommended Lawyer for Pharmaceuticals and Medical Products and Food Law\", :detail=\u0026gt;\"JUVE, 2014/15 - 2023/24\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as National Leader for Life Sciences - Regulatory\", :detail=\u0026gt;\"Who's Who Legal, 2021\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Reliable and excellent in terms of content\\\" \", :detail=\u0026gt;\"JUVE, 2020/21, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Very knowledgeable in life sciences and up to date on any developments on the market.\\\" \", :detail=\u0026gt;\"Legal 500 Deutschland 2021, Quoting Clients\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Fast + creative solutions, very good industry knowledge, skilled tactician especially in court proceedings.” \", :detail=\u0026gt;\"Legal 500 Deutschland 2025, Quoting Clients\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Direct, agile, assertive and client-oriented.” \", :detail=\u0026gt;\"Legal 500 Deutschland 2021, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Highly experienced in pharmaceutical, competition, food, trademark and European law” \", :detail=\u0026gt;\"Legal 500 Deutschland 2020, Quoting clients\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Stands out for his market-leading expertise in compliance to EU regulations in the life sciences sector\\\" \", :detail=\u0026gt;\"Who's Who Legal Germany, 2020\"}{{ FIELD }}Ulf Grundmann is a partner of the Government Matters Practice Group, and focuses on regulations and compliance regarding the pharmaceutical, medical devices, cosmetic and food industries, and on litigation in the European Union. For more than 28 years, Ulf has advised clients through all stages of the product life cycle, including product development, trademark clearance, labeling, advertising and promotion, product launch, distribution, licensing and compliance in the EU. He also handles all kinds of litigation related to the products, the distribution, intellectual property rights, competition and advertising. This includes aspects related to parallel imports, protection against falsified products, recalls, and product end-of-life. He litigates matters before German and European courts, including the General Court and the Court of Justice of the EU.\nUlf counsels clients in the European Union on regulatory, unfair competition and compliance laws, and represents clients before national and European authorities, including the European Commission. He also works with life science companies on corporate and financial transactions.\nAs frequent author, speaker and moderator at life sciences and food conferences, Ulf also serves as a lecturer at the Frankfurt School of Finance and Management as well as the DeutscheAnwaltsAkademie.\nLMG Life Sciences EMEA 2023 named Ulf a \"Parallel Import Lawyer of the Year\" for the second following year. JUVE 2023/24 named him a \"Leading Name\" for pharmaceutical and medical devices law for the third year in a row. Legal 500 Deutschland recommends him as leading lawyer in the categories Healthcare and Life Sciences, Consumer Goods and Food Law and Intellectual Property: Unfair Competition. He has been recognized among Germany's leading lawyers for pharmaceuticals, medical devices and food law by legal directories such as JUVE, Legal 500, Handelsblatt and best lawyers and Who's Who Legal for many years.\nUlf is counseling clients from the Frankfurt office and temporarily from the Brussels office. Ulf H Grundmann Partner Life Sciences Law Firm of the Year Germany LMG Life Sciences EMEA, 2023 \u0026amp; 2025 Law Firm Parallel Trade EMEA LMG Life Sciences EMEA, 2023 Recommended Lawyer for Life Sciences and Healthcare \u0026amp; Life Sciences Lexology Index (formerly Who's Who Legal) 2025 \"Quick and creative solutions, very good industry knowledge, skillful tactician, especially in court hearings\"  Legal 500 Deutschland 2025, Quoting clients Parallel Import Lawyer of the Year LMG Life Sciences EMEA Awards 2022,2023 and 2024 Winner of the Life Sciences category in Germany, an award based on client nominations  Client Choice Awards, 2022 \"Leading Name\" for Pharma- and Medical Devices Law JUVE, 2020/21-2023/24 Recommended Lawyer for Healthcare and Life Sciences, Consumer Products and Food Law, IP: Unfair Competition Legal 500 Deutschland, 2023 \"Ulf Grundmann has a lot of experience and excellent expertise regarding patent and trademark law in the life sciences.\" Legal 500 Deutschland 2023, Quoting clients \"Solves complex issues with a lot of creativity and offers alternative perspectives that [...] lead to better results.\" Legal 500 Deutschland 2023, Quoting clients Recognized one of Germany's Best Intellectual Property Dispute Resolution, Pharmaceuticals and Biotechnology Lawyers Handelsblatt and Best Lawyers, 2024-2025 “first choice\"; \"very satisfied\", \"excellent trial lawyer\"  JUVE, 2021/22, Quoting clients Recommended Lawyer for Pharmaceuticals and Medical Products and Food Law JUVE, 2014/15 - 2023/24 Recognized as National Leader for Life Sciences - Regulatory Who's Who Legal, 2021 \"Reliable and excellent in terms of content\"  JUVE, 2020/21, Quoting clients \"Very knowledgeable in life sciences and up to date on any developments on the market.\"  Legal 500 Deutschland 2021, Quoting Clients \"Fast + creative solutions, very good industry knowledge, skilled tactician especially in court proceedings.”  Legal 500 Deutschland 2025, Quoting Clients \"Direct, agile, assertive and client-oriented.”  Legal 500 Deutschland 2021, Quoting clients \"Highly experienced in pharmaceutical, competition, food, trademark and European law”  Legal 500 Deutschland 2020, Quoting clients \"Stands out for his market-leading expertise in compliance to EU regulations in the life sciences sector\"  Who's Who Legal Germany, 2020 Germany Frankfurt, Germany (Admitted 1/9/1995; Reg. # 127327)","searchable_name":"Ulf H. Grundmann","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":35,"capability_group_featured":null,"home_page_featured":null},{"id":436395,"version":1,"owner_type":"Person","owner_id":2963,"payload":{"bio":"\u003cp\u003eLauren\u0026rsquo;s practice focuses on the representation of healthcare clients including hospitals, healthcare companies, home health and hospice, and post-acute providers. Lauren regularly defends healthcare organizations in government enforcement matters including investigations and False Claims Act litigation. She also advises clients on internal investigations including remediation strategies such as voluntary refunds and self-disclosures. Lauren has significant\u0026nbsp;experience counseling clients on compliance program design and effectiveness strategies, as well as obligations stemming from Corporate Integrity Agreements. She also assists clients in government audits and appeals and advises clients in various regulatory compliance and reimbursement matters. Lauren serves as the Treasurer and CLE Committee Co-Chair\u0026nbsp;for the North Carolina Bar Association Health Law Section.\u0026nbsp;In addition, she is Certified in Healthcare Compliance (CHC), and\u0026nbsp;has served as a guest lecturer at the Georgia State College of Law and the Emory Rollins School of Public Health.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLauren earned her J.D., with honors, from the Emory University School of Law. During law school, she was awarded the James Colson Scholarship and served as a Notes and Comments Editor for the \u003cem\u003eEmory Law Journal\u003c/em\u003e. Lauren\u0026nbsp;earned her M.P.H., with a focus in health policy, from the Emory University Rollins School of Public Health. Lauren received her undergraduate degree in Public Policy, with highest honors, from the University of North Carolina at Chapel Hill, where she was elected to the Order of the Golden Fleece Honorary Society.\u003c/p\u003e","slug":"lauren-gennett","email":"lgennett@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":1,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":2,"source":"capabilities"},{"id":952,"guid":"952.smart_tags","index":3,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":4,"source":"smartTags"},{"id":826,"guid":"826.smart_tags","index":5,"source":"smartTags"},{"id":766,"guid":"766.smart_tags","index":6,"source":"smartTags"},{"id":1199,"guid":"1199.smart_tags","index":7,"source":"smartTags"}],"is_active":true,"last_name":"Gennett","nick_name":"Lauren","clerkships":[],"first_name":"Lauren","title_rank":9999,"updated_by":202,"law_schools":[{"id":659,"meta":{"degree":"J.D.","honors":"with honors, Order of the Coif","is_law_school":1,"graduation_date":"2012-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"S.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/laurenslive/","seodescription":null,"primary_title_id":14,"translated_fields":{"en":{"bio":"\u003cp\u003eLauren\u0026rsquo;s practice focuses on the representation of healthcare clients including hospitals, healthcare companies, home health and hospice, and post-acute providers. Lauren regularly defends healthcare organizations in government enforcement matters including investigations and False Claims Act litigation. She also advises clients on internal investigations including remediation strategies such as voluntary refunds and self-disclosures. Lauren has significant\u0026nbsp;experience counseling clients on compliance program design and effectiveness strategies, as well as obligations stemming from Corporate Integrity Agreements. She also assists clients in government audits and appeals and advises clients in various regulatory compliance and reimbursement matters. Lauren serves as the Treasurer and CLE Committee Co-Chair\u0026nbsp;for the North Carolina Bar Association Health Law Section.\u0026nbsp;In addition, she is Certified in Healthcare Compliance (CHC), and\u0026nbsp;has served as a guest lecturer at the Georgia State College of Law and the Emory Rollins School of Public Health.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eLauren earned her J.D., with honors, from the Emory University School of Law. During law school, she was awarded the James Colson Scholarship and served as a Notes and Comments Editor for the \u003cem\u003eEmory Law Journal\u003c/em\u003e. Lauren\u0026nbsp;earned her M.P.H., with a focus in health policy, from the Emory University Rollins School of Public Health. Lauren received her undergraduate degree in Public Policy, with highest honors, from the University of North Carolina at Chapel Hill, where she was elected to the Order of the Golden Fleece Honorary Society.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5829}]},"capability_group_id":2},"created_at":"2025-09-02T04:51:51.000Z","updated_at":"2025-09-02T04:51:51.000Z","searchable_text":"Gennett{{ FIELD }}Lauren’s practice focuses on the representation of healthcare clients including hospitals, healthcare companies, home health and hospice, and post-acute providers. Lauren regularly defends healthcare organizations in government enforcement matters including investigations and False Claims Act litigation. She also advises clients on internal investigations including remediation strategies such as voluntary refunds and self-disclosures. Lauren has significant experience counseling clients on compliance program design and effectiveness strategies, as well as obligations stemming from Corporate Integrity Agreements. She also assists clients in government audits and appeals and advises clients in various regulatory compliance and reimbursement matters. Lauren serves as the Treasurer and CLE Committee Co-Chair for the North Carolina Bar Association Health Law Section. In addition, she is Certified in Healthcare Compliance (CHC), and has served as a guest lecturer at the Georgia State College of Law and the Emory Rollins School of Public Health.\nLauren earned her J.D., with honors, from the Emory University School of Law. During law school, she was awarded the James Colson Scholarship and served as a Notes and Comments Editor for the Emory Law Journal. Lauren earned her M.P.H., with a focus in health policy, from the Emory University Rollins School of Public Health. Lauren received her undergraduate degree in Public Policy, with highest honors, from the University of North Carolina at Chapel Hill, where she was elected to the Order of the Golden Fleece Honorary Society. Counsel University of North Carolina at Chapel Hill University of North Carolina School of Law Emory University Emory University School of Law Emory University Emory University School of Law U.S. District Court for the Western District of North Carolina Georgia North Carolina American Health Law Association Health Care Compliance Association North Carolina Society of Health Care Attorneys North Carolina Bar Association Health Law Section","searchable_name":"Lauren S. Gennett","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}